Other gastritis (incl. Duodenitis)

K11_OTHGASTR

gastric mucosal hypertrophy: MC)nC)trier disease (MD) is a rare premalignant hyperproliferative gastropathy characterized by massive overgrowth of foveolar cells in the gastric lining, resulting in large gastric folds, and manifesting with epigastric pain, nausea, vomiting, peripheral edema and, less commonly, anorexia and weight loss.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K29.6, K29.7, K29.8, K29.9 Hospital discharge: ICD-9 — 5352\|535[5-6] Hospital discharge: ICD-8 — 5350[4-9] Cause of death: ICD-10 — K29.6, K29.7, K29.8, K29.9 Cause of death: ICD-9 — 5352\|535[5-6] Cause of death: ICD-8 — 5350[4-9] 2 out of 7 registries used, show all original rules.	12098
4. Check minimum number of events None	12098
5. Include endpoints None	12098
6. Filter based on genotype QC (FinnGen only)	10704

Control definitions (FinnGen only)

Control exclude: K11_OESSTODUO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	K11_OTHGASTR
CONTROL_EXCLUDE	K11_OESSTODUO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K29[6-9]
HD_ICD_9	5352\|535[5-6]
HD_ICD_8	5350[4-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K29[6-9]
COD_ICD_9	5352\|535[5-6]
COD_ICD_8	5350[4-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other gastritis (incl. Duodenitis) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	84729	42865	41015
Only index persons	70311	36865	33446
Unadjusted period prevalence (%)
Whole population	1.18	1.23	1.15
Only index persons	1.32	1.36	1.28
Median age at first event (years)
Whole population	59.54	61.51	57.52
Only index persons	58.04	59.45	56.49

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	10704	5475	5229
Unadjusted period prevalence (%)	2.17	1.94	2.40
Median age at first event (years)	59.42	57.88	61.02

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
11156: Matched controls
111560

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

135.3

318.3

160

UJF30

NOMESCO Finland

Ileoscopy through colon

3.1

314.0

1491

5299

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.6

307.7

1349

4087

UJD02

NOMESCO Finland

Gastroscopy

8.4

307.7

918

1173

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

445.9

307.7

1335

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

50.4

307.7

610

128

K29.8

ICD-10 Finland

Duodenitis

1265.7

307.7

1337

53509

ICD-8 Finland

Gastritis and duodenitis, Alia sive NUD

+∞

307.7

313

A02BC01

ATC

omeprazole; systemic

3.1

307.7

4099

17754

K29.6

ICD-10 Finland

Other gastritis

318.2

307.7

1654

K29.4

ICD-10 Finland

Chronic atrophic gastritis

24.4

307.7

346

146

A02BC02

ATC

pantoprazole; systemic

3.9

307.7

9063

58846

A02BC05

ATC

esomeprazole; systemic

3.3

307.7

5799

27606

N02AX02

ATC

tramadol; systemic, rectal

2.2

307.7

5584

34413

K30

ICD-10 Finland

Functional dyspepsia

5.7

307.7

1744

3485

UJF32

NOMESCO Finland

Coloscopy

3.9

307.7

4684

17576

K92.1

ICD-10 Finland

Melaena

4.2

307.7

933

2377

D64.9

ICD-10 Finland

Anaemia, unspecified

3.1

307.7

1853

6783

K29.1

ICD-10 Finland

Other acute gastritis

48.3

307.7

292

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.8

307.7

2030

8113

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

22.1

307.7

8130

12082

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.2

307.7

5290

24393

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

180.4

307.7

195

A02BA02

ATC

ranitidine; systemic

3.0

307.7

2852

11381

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

4.7

307.7

878

1971

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

38.2

307.7

199

K22.1

ICD-10 Finland

Ulcer of oesophagus

117.4

307.7

286

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

25.0

307.7

1895

907

K29.3

ICD-10 Finland

Chronic superficial gastritis

65.1

307.7

621

101

53508

ICD-8 Finland

Gastritis and duodenitis, Gastroduodenitis NUD

+∞

307.7

329

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.7

307.7

2940

9764

5355X

ICD-9 Finland

Gastritis and duodenitis, Unspecified gastritis and gastroduodenitis

+∞

307.7

444

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

7.0

307.7

1504

2430

A02BC04

ATC

rabeprazole; oral

3.6

307.7

1182

3553

A02BC03

ATC

lansoprazole; oral

3.1

307.7

4223

18262

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.7

307.7

2813

12529

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

111.0

307.7

334

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

12.2

307.7

1555

1462

R07.4

ICD-10 Finland

Chest pain, unspecified

2.4

307.7

3935

20622

K29.7

ICD-10 Finland

Gastritis, unspecified

368.8

307.7

6056

358

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.1

303.1

1435

5086

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

15.0

300.8

267

182

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

136.3

294.6

148

A04.8

ICD-10 Finland

Other specified bacterial intestinal infections

8.9

287.9

362

418

K92.0

ICD-10 Finland

Haematemesis

7.6

287.8

415

565

UJF92

NOMESCO Finland

Capsular endoscopy

7.4

283.8

417

580

R11

ICD-10 Finland

Nausea and vomiting

3.1

280.0

1289

4486

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

277.1

5985

40692

R06.0

ICD-10 Finland

Dyspnoea

2.1

275.5

3547

19978

K20

ICD-10 Finland

Oesophagitis

15.0

275.1

244

166

A03FA02

ATC

cisapride; oral, rectal

3.3

268.1

1082

3476

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

259.5

3328

18639

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

251.2

2877

15396

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

250.2

2250

10901

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

3.3

247.6

1026

3345

N03AX16

ATC

[U] pregabalin

2.2

247.3

2874

15454

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.5

244.3

1737

7563

R51.80

ICD-10 Finland

Headache

2.5

243.4

1860

8374

C03CA01

ATC

furosemide; systemic

2.0

240.7

4193

26080

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.2

235.1

2586

13571

H02AB06

ATC

prednisolone; systemic

1.9

233.9

5685

39379

K22.7

ICD-10 Finland

Barrett oesophagus

25.1

229.8

161

R13

ICD-10 Finland

Dysphagia

3.2

228.8

957

3133

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.3

222.5

593

1428

A02BDXX, ,

ATC

4.4

221.7

570

1335

P01AB01

ATC

metronidazole; oral, rectal

1.9

219.4

4475

29104

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

218.8

1973

9518

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

213.9

1793

8375

N06AX11

ATC

mirtazapine; oral

1.9

211.9

3991

25223

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

211.5

1335

5465

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

7.2

209.4

313

443

G44.2

ICD-10 Finland

Tension-type headache

2.4

207.5

1613

7281

R07.3

ICD-10 Finland

Other chest pain

2.5

195.8

1370

5882

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

6.8

193.6

307

463

R53

ICD-10 Finland

Malaise and fatigue

1.9

190.2

3022

17929

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

10.2

187.3

211

210

N03AX12

ATC

[U] gabapentin; oral

2.2

187.1

1950

9922

D01

ICPC

Abdominal pain/cramps general

2.4

186.4

1456

6566

A02BA04

ATC

nizatidine; systemic

2.8

183.6

1011

3849

A06AD11

ATC

lactulose; oral

2.1

182.5

1983

10247

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

88.0

182.4

C07AB07

ATC

bisoprolol; oral

1.8

181.9

5911

43449

M54.5

ICD-10 Finland

Low back pain

1.8

178.6

4033

26631

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

5.6

178.3

344

630

A02BA03

ATC

famotidine; systemic

3.8

177.7

568

1558

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

4.4

177.0

463

1097

J01MA02

ATC

ciprofloxacin; systemic

1.8

175.5

4593

31623

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

175.1

3189

19688

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.3

175.0

703

2237

R03AC02

ATC

salbutamol; inhalant

1.7

174.4

5884

43507

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

171.2

2665

15620

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

3.0

168.6

815

2888

R42

ICD-10 Finland

Dizziness and giddiness

1.9

167.4

2872

17354

N06AX21

ATC

duloxetine; oral

2.3

167.0

1381

6368

N05CF01

ATC

zopiclone; oral

1.8

163.6

3771

24899

J01MA12

ATC

levofloxacin; systemic

2.0

163.5

2296

12970

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.6

163.5

563

1623

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

3.3

163.4

657

2090

R12

ICD-10 Finland

Heartburn

2.7

161.3

963

3813

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.8

161.1

883

3346

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

157.8

4836

34487

C01DA14

ATC

isosorbide mononitrate; oral

2.0

156.9

2104

11678

D02

ICPC

Abdominal pain epigastric

2.9

156.7

765

2723

N05BA04

ATC

oxazepam; oral

1.8

153.9

2981

18626

AA1AD

NOMESCO Finland

CT of head and brain

1.8

152.9

3533

23243

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

151.0

2552

15274

N06AB04

ATC

citalopram; systemic

1.9

150.6

2351

13715

XF402

NOMESCO Finland

ECG with work load test

2.3

150.1

1330

6298

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

497.9

148.9

148

C03DA01

ATC

spironolactone; oral

2.1

148.7

1654

8566

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.7

145.7

821

3152

N06AA09

ATC

amitriptyline; systemic

2.3

145.6

1169

5306

K22.2

ICD-10 Finland

Oesophageal obstruction

41.7

144.7

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

142.5

1326

6399

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

140.1

2138

12344

M79.6

ICD-10 Finland

Pain in limb

1.7

139.9

4760

34546

J01DB01

ATC

cefalexin; oral

1.9

139.8

8980

76992

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

165.5

139.8

147

5356X

ICD-9 Finland

Gastritis and duodenitis, Duodenitis

+∞

138.8

133

A02BX02

ATC

sucralfate; oral

3.3

134.3

533

1679

K50.8

ICD-10 Finland

Other Crohn disease

6.1

133.2

232

385

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

132.4

2764

17530

A01

ICPC

Pain general/multiple sites

2.2

131.7

1233

5954

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

130.5

1989

11453

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.2

130.3

1304

6465

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

129.5

2385

14564

A07EA06

ATC

budesonide; oral, local oral

3.4

127.9

485

1485

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

6.2

127.5

218

355

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

127.5

3927

27605

N02BE01

ATC

paracetamol; systemic, rectal

2.0

127.4

9850

87727

L04AX01

ATC

azathioprine; systemic

3.2

127.2

538

1761

J01FF01

ATC

clindamycin; systemic

1.7

127.1

2962

19339

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

125.4

3146

20944

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.0

125.0

597

2095

ZX120

NOMESCO Finland

Intravenous

2.2

123.5

1142

5480

N06AX16

ATC

venlafaxine; oral

2.0

123.5

1434

7509

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

123.4

2055

12147

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

123.1

1375

7097

N05CD07

ATC

temazepam; oral

2.0

120.3

1443

7640

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

120.2

2058

12260

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

119.7

2779

18075

K50.9

ICD-10 Finland

Crohn disease, unspecified

5.7

119.0

223

397

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

117.1

2136

12958

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

5.9

116.9

210

359

R03BB04

ATC

tiotropium bromide; inhalant

2.1

116.9

1253

6362

I20.09

ICD-10 Finland

Unstable angina

2.5

116.2

774

3218

J01DA01

ATC

[U] cefalexin

1.6

115.3

6506

52381

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

114.6

2224

13730

K50.0

ICD-10 Finland

Crohn disease of small intestine

5.6

114.4

217

391

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

114.0

4504

33382

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

113.7

875

3883

N05BA01

ATC

diazepam; systemic, rectal

2.0

113.5

1464

7940

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

113.5

2928

19542

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.8

113.2

606

2260

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.4

113.1

873

3879

A03CA02

ATC

clidinium and psycholeptics; oral

2.6

113.0

720

2929

M03BX02

ATC

tizanidine; oral

1.6

112.7

6279

50286

K59.1

ICD-10 Finland

Functional diarrhoea

2.6

112.3

699

2812

R02

ICPC

Shortness of breath/dyspnoea

1.9

111.9

1590

8906

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.3

111.9

931

4271

M25.5

ICD-10 Finland

Pain in joint

1.6

111.7

3369

23381

WX002

NOMESCO Finland

Sedation and analgesia

1.8

110.7

2139

13173

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.9

110.5

1564

8747

127

Kela drug reimbursment

Transplant complication

5.0

110.3

239

485

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

109.0

3168

21755

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

108.9

1794

10529

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

+∞

108.5

104

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

107.7

1469

8110

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

360.8

107.5

108

C10AC01

ATC

colestyramine; oral

3.5

106.6

369

1065

B03BA03

ATC

hydroxocobalamin; parenteral

2.5

106.0

695

2865

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

105.9

926

4333

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.3

105.9

845

3805

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

105.8

2829

18998

C07AB02

ATC

metoprolol; systemic

1.7

105.8

2368

15175

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.0

105.7

1245

6532

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

33.7

105.2

J02AC01

ATC

fluconazole; systemic

1.6

105.1

3707

26624

R52.9

ICD-10 Finland

Pain, unspecified

2.1

104.4

1172

6040

A10AB05

ATC

insulin aspart; parenteral

2.2

104.2

934

4415

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

104.0

1158

5950

J01AA02

ATC

doxycycline; systemic

1.6

103.7

8331

71866

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

103.2

1250

6619

N02AA05

ATC

oxycodone; systemic

1.7

103.2

2209

13972

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

103.0

1383

7588

J01CA04

ATC

amoxicillin; systemic

1.6

102.8

8521

73967

N05AH04

ATC

quetiapine; oral

1.8

102.6

1779

10588

M01AB55

ATC

diclofenac, combinations; oral

2.3

102.5

800

3567

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

155.8

102.3

108

ZXD05

NOMESCO Finland

Urgent procedure

1.6

102.2

3137

21766

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

102.2

1327

7198

M48.0

ICD-10 Finland

Spinal stenosis

1.9

101.8

1494

8439

C07AA05

ATC

propranolol; systemic

1.8

101.7

1978

12171

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

101.4

2250

14364

1310

FHL

Esophagogastroscopy

16.9

101.3

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

101.0

862

3992

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

33.9

100.6

A07EC02

ATC

mesalazine; oral, rectal

2.6

100.3

595

2335

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

99.7

3559

25559

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

99.3

2911

19949

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

12.7

99.0

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

98.6

1816

10990

L04AA06

ATC

mycophenolic acid; systemic

4.1

98.2

273

676

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

97.8

1155

6055

K26.3

ICD-10 Finland

Duodenal ulcer, acute without haemorrhage or perforation

487.2

97.6

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.8

97.4

495

1794

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

96.6

2727

18492

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

96.3

1795

10894

A10AE04

ATC

insulin glargine; parenteral

2.0

95.9

1147

6039

J01FA09

ATC

clarithromycin; systemic

1.6

95.8

3052

21302

K86.1

ICD-10 Finland

Other chronic pancreatitis

6.5

95.3

156

243

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

11.2

95.1

100

H02AB04

ATC

methylprednisolone; systemic

1.8

94.8

1544

8997

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.9

94.7

449

1566

B81

ICPC

Anaemia vit B12/folate deficiency

2.8

93.9

474

1711

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.5

93.3

228

511

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

93.3

1374

7754

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.4

92.8

648

2747

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.2

92.7

388

1260

N02BF01

ATC

gabapentin; oral

2.0

92.4

1154

6164

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

91.9

2625

17818

L03

ICPC

Low back symptom/complaint

1.6

91.8

2958

20665

UKC02

NOMESCO Finland

Cystoscopy

1.7

90.8

1867

11631

K59.0

ICD-10 Finland

Constipation

2.4

90.5

683

2997

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

90.5

2065

13233

S18

ICPC

Laceration/cut

1.5

90.4

5123

40391

R52.2

ICD-10 Finland

Other chronic pain

2.9

90.3

444

1580

A02BD02

ATC

lansoprazole, tetracycline and metronidazole; systemic

3.6

89.4

299

843

A01AB09

ATC

miconazole; local oral

2.1

89.4

943

4739

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.5

89.4

318

934

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

89.4

2262

14885

A07AA02

ATC

nystatin; oral

2.3

88.7

681

3011

5301A

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]

+∞

88.6

N02BF02

ATC

pregabalin; oral

2.2

88.5

769

3581

M79.1

ICD-10 Finland

Myalgia

1.8

88.2

1479

8680

R50.9

ICD-10 Finland

Fever, unspecified

1.8

88.2

1650

10001

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

88.0

4158

31526

UJF02

NOMESCO Finland

Peroral enteroscopy

8.6

87.5

112

132

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.7

87.0

504

1953

J01FA06

ATC

roxithromycin; oral

1.5

87.0

4016

30283

G47.3

ICD-10 Finland

Sleep apnoea

1.6

86.9

2380

15959

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.9

86.2

1116

6028

R63.4

ICD-10 Finland

Abnormal weight loss

2.6

86.2

507

1980

K50.1

ICD-10 Finland

Crohn disease of large intestine

5.4

86.2

169

314

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

8.7

85.9

109

127

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

85.8

1066

5677

H02AB07

ATC

prednisone; oral

1.8

85.7

1462

8620

XJC10

NOMESCO Finland

Oesophageal pH monitoring

25.1

85.6

TK800

NOMESCO Finland

Hemodialysis

3.5

85.6

298

863

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

85.4

5181

41240

AN1

Coronary angiography

1.9

85.2

1294

7362

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.1

85.0

233

571

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

84.7

3841

28816

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

114.7

84.0

L04AD02

ATC

tacrolimus; systemic

5.7

83.7

155

273

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.1

83.5

355

1163

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.6

83.4

518

2077

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.5

83.2

528

2139

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

10.1

83.1

M04AA01

ATC

allopurinol; systemic

1.8

83.0

1573

9556

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

82.2

2608

18076

M01AH02

ATC

rofecoxib; oral

1.8

82.1

1387

8148

R05

ICD-10 Finland

Cough

1.6

81.9

2200

14654

M54.2

ICD-10 Finland

Cervicalgia

2.1

81.6

843

4199

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.9

81.5

1153

6407

A04

ICPC

Weakness/tiredness general

1.7

81.5

1678

10429

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

81.4

1471

8812

JJC00

NOMESCO Finland

Allogenic transplantation of liver

15.6

81.1

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.4

80.8

561

2370

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.3

80.7

304

926

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

80.5

3073

22176

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.0

80.4

363

1231

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

80.4

841

4207

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

80.3

778

3780

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

7.5

80.3

115

155

R06AE07

ATC

cetirizine; oral

1.5

80.3

4259

32883

N01

ICPC

Headache

2.0

80.1

984

5215

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

80.1

1412

8395

L17

ICPC

Foot/toe symptom/complaint

1.5

80.1

3219

23483

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

79.8

934

4866

C08CA01

ATC

amlodipine; oral

1.5

79.7

4340

33669

M01AH01

ATC

celecoxib; oral

1.7

79.6

1874

12063

XJ110

NOMESCO Finland

Respiratory helicobactery test

18.6

79.5

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

79.3

6925

58776

C10AA01

ATC

simvastatin; oral

1.5

79.3

4720

37241

K70.1

ICD-10 Finland

Alcoholic hepatitis

7.8

78.9

109

141

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.2

78.4

726

3466

T90

ICPC

Diabetes non-insulin dependent

1.5

78.2

2751

19478

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

77.9

4422

34532

M79.7

ICD-10 Finland

Fibromyalgia

3.0

77.9

355

1211

A10BA02

ATC

metformin; oral

1.5

77.8

3170

23162

R10.0

ICD-10 Finland

Acute abdomen

2.9

77.5

383

1366

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

77.5

1300

7612

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

77.3

709

3370

F10.24

ICD-10 Finland

Alcohol depence active use

4.5

77.3

191

432

A11

ICPC

Chest pain NOS

2.0

77.3

960

5105

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

77.2

489

1979

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

76.8

730

3519

N06AX03

ATC

mianserin; oral

2.4

76.6

541

2302

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.2

75.5

309

990

K22.9

ICD-10 Finland

Disease of oesophagus, unspecified

19.1

75.3

B01AC04

ATC

clopidogrel; oral

1.6

75.3

1893

12372

Z94.4

ICD-10 Finland

Liver transplant status

10.7

74.9

SPAT1263

SPAT

Sampling

1.5

74.7

4156

32256

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.2

74.6

303

966

J37.0

ICD-10 Finland

Chronic laryngitis

2.9

74.4

352

1226

N30.0

ICD-10 Finland

Acute cystitis

1.7

74.1

1775

11457

B01AB05

ATC

enoxaparin; parenteral

1.5

73.8

3365

25106

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.3

73.6

288

898

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

73.5

2037

13628

Z2221

NOMESCO Finland

Medical doctor

1.5

73.3

2706

19315

N06AA12

ATC

doxepin; systemic

2.3

73.3

584

2620

B82

ICPC

Anaemia other/unspecified

2.9

73.2

365

1308

K85

ICD-10 Finland

Acute pancreatitis

3.9

73.1

220

577

A02BA07

ATC

ranitidine bismuth citrate; oral

9.2

73.0

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

72.9

4441

35012

D07AC01

ATC

betamethasone; topical

1.5

72.1

3743

28617

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

71.9

7172

61812

XF404

NOMESCO Finland

Ambulatory ECG

1.9

71.6

960

5232

B80

ICPC

Iron deficiency anaemia

3.1

71.6

301

980

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

71.5

3756

28770

N05CF02

ATC

zolpidem; oral

1.7

71.4

1681

10791

K55.8

ICD-10 Finland

Other vascular disorders of intestine

8.4

71.4

112

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.0

71.3

322

1092

K70.4

ICD-10 Finland

Alcoholic hepatic failure

9.3

70.9

K22.8

ICD-10 Finland

Other specified diseases of oesophagus

23.3

70.6

Z50.1

ICD-10 Finland

Other physical therapy

2.2

69.9

594

2736

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

69.9

734

3673

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

69.4

538

2385

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.7

69.4

390

1488

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.6

69.2

2072

14091

R18

ICD-10 Finland

Ascites

3.2

69.2

277

876

Z3226

NOMESCO Finland

Physiotherapist

1.6

69.1

1839

12163

R03DC03

ATC

montelukast; oral

1.7

69.0

1538

9730

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.2

68.9

626

2962

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.9

68.9

328

1146

D06

ICPC

Abdominal pain localized other

1.9

68.9

896

4833

N07BB01

ATC

disulfiram; oral

2.6

68.5

427

1714

A10AC01

ATC

insulin (human); parenteral

2.0

68.4

820

4302

L01

ICPC

Neck symptom/complaint

1.7

68.3

1569

10001

I20.00

ICD-10 Finland

Unstable angina

2.7

68.2

379

1437

Z2446

NOMESCO Finland

Social worker

2.1

68.2

644

3094

R03BA05

ATC

fluticasone; inhalant

1.6

68.1

1721

11235

A02BX05

ATC

bismuth subcitrate; oral

4.2

67.7

184

448

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

67.6

2535

18108

SPAT1254

SPAT

Administration of medicine

1.7

67.5

1554

9909

N18.8

ICD-10 Finland

Other chronic renal failure

2.9

67.3

327

1155

K26.7

ICD-10 Finland

Duodenal ulcer, chronic without haemorrhage or perforation

231.4

67.3

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

231.4

67.3

N03AE01

ATC

clonazepam; systemic

2.2

67.2

600

2819

WX892

NOMESCO Finland

Monitored bed care

2.0

67.1

836

4442

M01AX17

ATC

nimesulide; oral

1.5

67.0

2452

17417

M01AB05

ATC

diclofenac; systemic, rectal

1.4

66.8

6671

57098

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

66.7

747

3825

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.7

66.5

355

1319

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.6

66.4

409

1632

M01AE02

ATC

naproxen; oral, rectal

1.4

66.1

5474

45313

K29.2

ICD-10 Finland

Alcoholic gastritis

140.9

65.9

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.3

65.6

500

2200

R01AD09

ATC

mometasone; nasal

1.4

65.5

4202

33245

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

65.3

741

3812

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.3

65.2

252

780

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

65.1

471

2025

Angiography of the heart and coronary arteries

2.0

65.1

714

3628

D11

ICPC

Diarrhoea

1.8

65.1

1118

6574

R00.2

ICD-10 Finland

Palpitations

2.0

64.8

769

4017

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

5.0

64.7

140

284

A07AA11

ATC

rifaximin; oral

10.5

64.7

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

64.6

573

2684

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

64.5

2868

21176

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.3

64.4

502

2230

R60.0

ICD-10 Finland

Localized oedema

1.7

64.3

1406

8836

K26.4

ICD-10 Finland

Duodenal ulcer, chronic or unspecified with haemorrhage

632.0

63.9

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.7

63.9

203

553

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

63.5

6994

60612

XJC00

NOMESCO Finland

Oesophageal manometry

26.0

63.4

A11CC03

ATC

alfacalcidol; systemic

2.9

63.4

298

1034

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

8.8

63.4

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

63.4

2494

17956

Z3231

NOMESCO Finland

Registered nurse

1.5

63.3

2785

20506

R07.0

ICD-10 Finland

Pain in throat

2.1

62.9

640

3163

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

62.7

5337

44228

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

62.7

1107

6559

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.1

62.5

632

3115

N02AC04

ATC

dextropropoxyphene; oral

2.4

62.4

435

1839

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.3

62.3

243

756

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

62.3

482

2134

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.6

62.2

381

1516

JAH01

NOMESCO Finland

Laparoscopy

2.4

62.1

450

1936

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

61.7

820

4449

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.8

61.7

317

1154

JN4AD

NOMESCO Finland

Body CT examination

1.7

61.7

1285

7968

N05BA12

ATC

alprazolam; oral

1.8

61.7

966

5522

3AC01, ,

NOMESCO Finland

5.0

61.6

134

273

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

61.5

653

3277

53505

ICD-8 Finland

Gastritis and duodenitis, Duodenitis chronica

+∞

61.5

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

61.3

4445

35798

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

61.2

466

2048

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

61.1

1475

9498

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

60.9

3770

29532

N06AB10

ATC

escitalopram; oral

1.6

60.8

1774

11956

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

60.7

800

4329

A10AE05

ATC

insulin detemir; parenteral

2.2

60.7

566

2705

R4110

NOMESCO Finland

Physiotherapy

1.5

60.6

2845

21181

M02AA07

ATC

piroxicam; topical

1.4

60.5

3640

28364

K90.0

ICD-10 Finland

Coeliac disease

2.8

60.5

313

1144

N05AA02

ATC

levomepromazine; systemic

2.4

60.5

424

1797

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

60.4

543

2557

A10BH01

ATC

sitagliptin; oral

1.8

60.2

1057

6247

C05AA08

ATC

fluocortolone; rectal, topical

1.7

60.1

1332

8392

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.0

60.1

695

3597

N06AB03

ATC

fluoxetine; oral

1.7

60.1

1144

6920

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.2

60.0

531

2485

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.4

60.0

411

1724

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

59.8

838

4624

B01AA03

ATC

warfarin; systemic

1.5

59.8

2146

15130

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.7

59.8

326

1224

J01EA01

ATC

trimethoprim; systemic

1.5

59.4

2528

18454

R03BA02

ATC

budesonide; inhalant

1.6

59.2

1691

11332

R55

ICD-10 Finland

Syncope and collapse

1.7

59.2

1215

7498

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

59.1

2905

21797

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.3

59.0

222

676

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

58.9

917

5230

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

15.5

58.8

N03AX09

ATC

lamotrigine; oral

2.4

58.7

421

1802

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

58.7

1344

8536

R96

ICPC

Asthma

1.8

58.7

1002

5874

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.6

58.5

194

544

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

58.4

1083

6501

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

58.2

1237

7703

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

58.2

682

3545

L28

ICPC

Limited function/disability (L)

1.5

58.2

2101

14823

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

58.2

1416

9130

S06.0

ICD-10 Finland

Concussion

1.7

58.1

1072

6425

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

57.4

906

5186

R4190

NOMESCO Finland

Nutritional therapy

2.4

57.4

394

1654

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.6

57.4

189

528

5308A

ICD-9 Finland

Diseases of oesophagus, Other specified disorders of oesophagus[HERNIA HIATUS OESOPHAGI (""""SLIDING HERNIA"""")]

+∞

57.3

5350A

ICD-9 Finland

Gastritis and duodenitis, Acute gastritis

+∞

57.3

D03

ICPC

Heartburn

2.5

57.2

355

1421

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

57.2

1653

11100

J01DA09

ATC

[U] cefadroxil

1.5

57.2

2491

18246

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.4

57.1

409

1750

L08

ICPC

Shoulder symptom/complaint

1.5

57.1

2315

16717

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.1

57.1

549

2654

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.0

57.0

622

3152

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

56.7

2045

14413

C10AA05

ATC

atorvastatin; oral

1.4

56.5

4585

37463

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

56.4

3558

27872

Z94.0

ICD-10 Finland

Kidney transplant status

4.3

56.4

146

343

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

56.3

477

2192

107

Kela drug reimbursment

Pernicious anaemia

3.3

56.3

212

646

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

56.2

1225

7677

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.6

56.1

344

1369

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.7

56.1

177

480

M01AC06

ATC

meloxicam; systemic, rectal

1.4

55.7

3539

27741

K55.2

ICD-10 Finland

Angiodysplasia of colon

5.5

55.5

107

196

S22.3

ICD-10 Finland

Fracture of rib

1.9

55.5

762

4176

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.7

55.4

307

1163

J01MA14

ATC

moxifloxacin; systemic

1.8

55.1

926

5400

D64.8

ICD-10 Finland

Other specified anaemias

3.1

55.0

237

783

A46

ICD-10 Finland

Erysipelas

1.6

54.8

1630

11008

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

54.6

1107

6804

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

54.5

1004

6009

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.8

54.4

123

259

K02.1

ICD-10 Finland

Caries of dentine

1.4

54.4

5549

46916

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

5.1

54.3

115

229

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

54.1

1846

12845

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

54.1

628

3252

N06AB06

ATC

sertraline; oral

1.7

54.0

986

5885

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

6.7

53.7

128

SPAT1301

SPAT

No procedures

1.4

53.7

3118

24034

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.6

53.5

305

1172

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.0

53.3

150

375

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

53.3

2465

18223

R03BA01

ATC

beclometasone; inhalant

1.6

53.2

1361

8868

G43.9

ICD-10 Finland

Migraine, unspecified

2.2

53.1

466

2172

EBA00

NOMESCO Finland

Extraction of tooth

1.4

53.0

3496

27524

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

53.0

3554

28058

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

52.7

574

2906

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

52.4

1934

13670

R01AD08

ATC

fluticasone; nasal

1.4

52.2

2548

19016

E0000UV, ,

ATC

1.4

52.2

4054

32764

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

12.1

52.1

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

52.1

2848

21695

D09

ICPC

Nausea

2.3

52.0

412

1842

C07AG02

ATC

carvedilol; oral

1.9

51.8

665

3563

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.6

51.6

316

1257

SFA10

NOMESCO Finland

One-surface restoration

1.4

51.6

5194

43678

M10.9

ICD-10 Finland

Gout, unspecified

1.8

51.5

800

4553

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

51.4

3739

29882

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

51.2

1432

9526

A01AB04

ATC

amphotericin B; local oral

2.1

51.1

491

2372

JDA32

NOMESCO Finland

Endoscopic injection in stomach or pylorus

19.1

51.0

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

50.9

834

4822

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

50.9

639

3397

ZXE00

NOMESCO Finland

One hour or less

1.4

50.9

3733

29858

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

50.8

1284

8337

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

50.7

770

4353

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

3.2

50.6

202

638

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.2

50.6

453

2129

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.0

50.6

227

768

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

50.3

736

4112

E66.8

ICD-10 Finland

Other obesity

2.1

50.2

491

2388

XG410

NOMESCO Finland

Flow-volume spirometry

2.3

50.1

391

1737

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.4

49.8

361

1553

L04AD01

ATC

ciclosporin; systemic

3.1

49.8

206

665

M01AH05

ATC

etoricoxib; oral

1.3

49.6

6014

51884

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

49.5

631

3372

P15

ICPC

Chronic alcohol abuse

2.6

49.2

291

1138

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

49.2

777

4442

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.7

49.1

269

1013

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.6

49.0

117

258

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

49.0

429

1998

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

48.9

792

4562

N17

ICPC

Vertigo/dizziness

1.6

48.8

1307

8599

S97

ICPC

Chronic ulcer skin

1.8

48.8

715

3996

UJH02

NOMESCO Finland

Anoscopy

2.2

48.6

407

1861

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

48.6

409

1875

Z71.9

ICD-10 Finland

Counselling, unspecified

1.8

48.5

798

4619

J01FA10

ATC

azithromycin; systemic

1.3

48.5

5228

44263

N05BE01

ATC

buspirone; oral

2.6

48.4

292

1154

I50.0

ICD-10 Finland

Congestive heart failure

1.7

48.3

869

5161

M54.1

ICD-10 Finland

Radiculopathy

2.2

48.3

406

1860

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.5

48.3

317

1304

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.3

48.2

363

1587

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

48.2

419

1946

K22.0

ICD-10 Finland

Achalasia of cardia

246.1

48.0

A12AA04

ATC

calcium carbonate; oral

3.2

48.0

191

602

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.3

47.9

365

1604

Y0599

ICD-8 Finland

Investigation of digestive system

3.2

47.8

194

619

R03AC03

ATC

terbutaline; inhalant

1.6

47.6

1269

8336

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

14.4

47.6

R03BA08

ATC

ciclesonide; inhalant

1.8

47.5

792

4600

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

47.4

2139

15696

SPAT1285

SPAT

Provision of consultation response

2.0

47.3

536

2750

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

47.2

945

5777

B03XA02

ATC

darbepoetin alfa; parenteral

2.7

47.2

250

925

XQ800

NOMESCO Finland

Prick test

1.9

47.1

594

3163

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.9

46.9

674

3743

53503

ICD-8 Finland

Gastritis and duodenitis, Gastritis chronica NUD

+∞

46.9

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

46.9

638

3482

H02AB09

ATC

hydrocortisone; systemic

2.8

46.9

242

884

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

46.8

1123

7191

E87.6

ICD-10 Finland

Hypokalaemia

2.3

46.8

380

1716

D13.3

ICD-10 Finland

Benign neoplasm: Other and unspecified parts of small intestine

7.8

46.7

L04AA01

ATC

[U] ciclosporin

3.4

46.7

166

488

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

46.7

2362

17691

K08.80

ICD-10 Finland

Toothache NOS

1.8

46.5

771

4472

A05AA02

ATC

ursodeoxycholic acid; oral

3.4

46.5

170

509

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

46.4

659

3646

R05

ICPC

Cough

1.4

46.4

2373

17807

J01CA08

ATC

pivmecillinam; oral

1.4

46.3

3608

29029

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

46.2

664

3687

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

46.1

675

3769

A02BX

ATC

Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

3.5

46.0

162

473

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.3

45.9

374

1691

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

45.9

752

4346

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

7.8

45.9

UJK02

NOMESCO Finland

ERCP

2.5

45.8

298

1221

J46

ICD-10 Finland

Status asthmaticus

2.5

45.5

292

1188

XA402

NOMESCO Finland

ENMG

2.6

45.5

266

1035

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.1

45.5

418

1984

1370

FHL

Colonoscopy, whole colon

6.1

45.5

131

L60.0

ICD-10 Finland

Ingrowing nail

2.0

45.4

477

2381

JAH00

NOMESCO Finland

Laparotomy

2.5

45.4

302

1250

A06AC51

ATC

ispaghula, combinations; oral

2.1

45.3

454

2227

R07.2

ICD-10 Finland

Precordial pain

2.7

45.3

241

894

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.3

45.3

357

1592

G04CA02

ATC

tamsulosin; oral

1.4

45.2

2531

19279

A05

ICPC

Feeling ill

2.0

45.2

496

2517

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.7

45.1

253

964

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

45.1

483

2428

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

4.2

45.0

118

280

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

45.0

1315

8815

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.1

44.9

189

616

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

5.3

44.9

171

205

Kela drug reimbursment

Chronic hypertension

1.4

44.6

2891

22562

I25.2

ICD-10 Finland

Old myocardial infarction

1.8

44.3

725

4186

M54.3

ICD-10 Finland

Sciatica

1.9

44.3

579

3119

L02

ICPC

Back symptom/complaint

1.7

44.1

912

5620

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.5

43.9

275

1107

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.8

43.8

134

356

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

43.8

1065

6838

Z71.8

ICD-10 Finland

Other specified counselling

1.4

43.8

3207

25502

D10

ICPC

Vomiting

2.1

43.5

448

2220

A10BH05

ATC

linagliptin; oral

1.9

43.5

573

3094

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

43.4

1255

8389

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

43.3

711

4109

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

43.3

1567

10992

WVA20

NOMESCO Finland

Medicine administration

2.4

43.2

304

1290

P06

ICPC

Sleep disturbance

1.6

43.2

1144

7494

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

43.2

522

2739

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.4

43.1

304

1292

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

43.1

959

6023

SPAT1262

SPAT

Handing over of treatment supplies

1.5

43.0

1747

12537

SPAT1240

SPAT

Therapeutic discussion

1.7

42.9

791

4724

SPAT1260

SPAT

Consultation of another employee

1.5

42.9

1687

12028

K76.9

ICD-10 Finland

Liver disease, unspecified

3.3

42.9

159

480

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.7

42.9

820

4947

K22.5

ICD-10 Finland

Diverticulum of oesophagus, acquired

80.4

42.9

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

42.8

250

972

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

42.7

554

2975

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

42.6

814

4910

N05BA02

ATC

chlordiazepoxide; systemic

2.6

42.6

245

946

J01MA01

ATC

ofloxacin; systemic

1.7

42.6

804

4835

A03CA05

ATC

glycopyrronium bromide and psycholeptics; systemic

3.6

42.6

138

382

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

42.5

661

3760

6241

FHL

Fund application (Nissen)

55.8

42.4

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

9.5

42.4

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

2.9

42.3

205

724

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

42.2

445

2224

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.6

42.2

252

991

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

3.7

42.1

134

366

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.9

42.1

199

693

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.7

42.1

135

371

C09AA05

ATC

ramipril; oral

1.4

42.0

2643

20488

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

41.9

1538

10813

H57.1

ICD-10 Finland

Ocular pain

2.2

41.9

357

1645

A28

ICPC

Limited function/disability NOS

1.4

41.9

1961

14448

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.2

41.7

343

1557

V03AE02

ATC

sevelamer; oral

5.6

41.7

139

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.4

41.7

305

1318

M02AA10

ATC

ketoprofen; topical

1.5

41.6

1542

10861

K86.3

ICD-10 Finland

Pseudocyst of pancreas

6.1

41.6

119

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.1

41.6

391

1873

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

41.4

1614

11484

WZC00, ,

SPAT

1.5

41.3

1418

9830

D50

ICD-10 Finland

Iron deficiency anaemia

2.7

41.3

218

806

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

41.2

2570

19881

J01MA06

ATC

norfloxacin; oral

1.6

41.2

1209

8103

ZXA05

NOMESCO Finland

Left side

1.4

41.1

2424

18580

R06.4

ICD-10 Finland

Hyperventilation

3.3

41.0

155

474

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

40.9

749

4464

G50.1

ICD-10 Finland

Atypical facial pain

3.0

40.9

177

587

R21

ICPC

Throat symptom/complaint

1.5

40.9

1631

11654

ZXA00

NOMESCO Finland

Right side

1.4

40.8

2589

20079

R51

ICD-10 Finland

Headache

2.0

40.8

458

2342

W19

ICD-10 Finland

Unspecified fall

1.6

40.8

1000

6429

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

40.7

435

2185

Z01.7

ICD-10 Finland

Laboratory examination

1.5

40.7

1588

11296

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

40.7

927

5853

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

40.7

896

5610

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

40.6

402

1963

Z01.2

ICD-10 Finland

Dental examination

1.3

40.5

4206

35100

N03AF01

ATC

carbamazepine; oral, rectal

2.0

40.4

486

2545

SFA20

NOMESCO Finland

Two-surface restoration

1.3

40.2

5412

46781

R51.81

ICD-10 Finland

Facial pain NOS

2.6

40.1

228

875

P03

ICPC

Feeling depressed

1.7

40.0

739

4414

C08CA05

ATC

nifedipine; systemic

1.8

40.0

618

3506

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

40.0

521

2803

N06AX05

ATC

trazodone; oral

2.6

39.9

232

901

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

39.8

2686

21022

D97

ICPC

Liver disease NOS

5.2

39.8

156

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

39.8

549

3007

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

39.8

378

1817

SPAT1104

SPAT

Monitoring of emergency patient

1.8

39.8

620

3527

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.9

39.7

179

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

39.5

1793

13119

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.4

39.5

280

1193

X58

ICD-10 Finland

Exposure to other specified factors

1.5

39.5

1317

9072

J20

ICD-10 Finland

Acute bronchitis

1.6

39.5

944

6031

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.9

39.4

519

2801

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

39.4

1262

8618

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.9

39.2

540

2956

137

Kela drug reimbursment

Uraemia requiring dialysis

4.1

39.2

107

262

53502

ICD-8 Finland

Gastritis and duodenitis, Gastritis acuta NUD

5.1

39.2

162

P76

ICPC

Depressive disorder

1.9

39.1

521

2822

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.2

39.1

343

1599

SPAT1097

SPAT

Recording of ECG

1.5

39.0

1425

9997

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

39.0

668

3907

R03AC13

ATC

formoterol; inhalant

1.9

38.8

476

2510

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

38.7

1330

9215

R03AC12

ATC

salmeterol; inhalant

2.0

38.7

448

2316

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

38.6

1605

11546

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.6

38.5

1088

7225

N03AG01

ATC

valproic acid; systemic, rectal

1.9

38.5

539

2966

N04BC05

ATC

pramipexole; oral

1.7

38.5

734

4422

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.5

38.4

238

953

JF1AD

NOMESCO Finland

Small bowel CT

4.8

38.4

184

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.6

38.4

233

924

P01BA02

ATC

hydroxychloroquine; oral

1.7

38.4

753

4572

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

5.5

38.3

136

F45.0

ICD-10 Finland

Somatization disorder

6.5

38.2

K72.1

ICD-10 Finland

Chronic hepatic failure

10.8

38.2

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

2.8

38.1

193

698

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.1

38.1

104

255

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

38.0

2184

16638

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

37.9

728

4394

R03DA04

ATC

theophylline; systemic, rectal

1.9

37.9

524

2873

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

37.8

601

3438

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.5

37.8

246

1008

A07AA09

ATC

vancomycin; oral

3.0

37.8

165

550

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

37.8

510

2774

L13

ICPC

Hip symptom/complaint

1.4

37.7

1904

14185

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.9

37.7

464

2449

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.8

37.7

536

2965

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

7.4

37.7

53504

ICD-8 Finland

Gastritis and duodenitis, Duodenitis acuta

+∞

37.5

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.2

37.4

339

1600

A10BB12

ATC

glimepiride; oral

1.7

37.4

711

4279

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.9

37.4

485

2604

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

37.4

1198

8176

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

37.3

2449

19053

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

37.3

508

2772

K72.9

ICD-10 Finland

Hepatic failure, unspecified

5.0

37.2

158

H01

ICPC

Ear pain/earache

1.6

37.2

990

6484

R04.2

ICD-10 Finland

Haemoptysis

2.1

37.2

352

1691

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

37.1

3728

30870

A03

ICPC

Fever

1.5

37.0

1434

10171

L04AX03

ATC

methotrexate; systemic

1.6

37.0

885

5651

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

37.0

700

4208

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

37.0

672

3995

H03AA01

ATC

levothyroxine sodium; systemic

1.4

37.0

2133

16252

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

4.3

36.8

223

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.3

36.8

274

1193

WX402

NOMESCO Finland

General anaesthesia

1.4

36.7

2059

15611

R01AD58

ATC

fluticasone, combinations; nasal

1.4

36.7

1993

15030

F61.0

ICD-10 Finland

Mixed personality disorders

3.1

36.6

152

492

N19

ICD-10 Finland

Unspecified kidney failure

2.0

36.5

408

2083

JDA35

NOMESCO Finland

Endoscopic contact coagulation in stomach or pylorus

13.6

36.5

C10AX09

ATC

ezetimibe; oral

1.4

36.4

1699

12476

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

36.4

876

5602

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

36.4

951

6202

SPAT1255

SPAT

Intravenous administration of medicine

1.7

36.3

656

3893

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.0

36.2

407

2082

KMAK, ,

NOMESCO Finland

1.3

36.1

4563

38906

U07

ICPC

Urine symptom/complaint other

1.6

36.1

851

5415

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.5

36.0

198

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.9

36.0

482

2616

C09AA02

ATC

enalapril; systemic

1.4

35.8

1986

15020

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.6

35.7

118

331

J45

ICD-10 Finland

Asthma

1.6

35.7

912

5914

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.1

35.5

152

501

J01AA07

ATC

tetracycline; systemic

1.5

35.5

1171

8035

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

35.5

546

3092

A10BK03

ATC

empagliflozin; oral

1.5

35.5

1040

6957

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.5

35.5

235

971

R35

ICD-10 Finland

Polyuria

1.7

35.5

683

4124

R09

ICPC

Sinus symptom/complaint

1.7

35.4

662

3965

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

35.4

753

4669

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.4

35.3

125

367

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

35.3

310

1446

K56.7

ICD-10 Finland

Ileus, unspecified

2.7

35.3

197

750

A10AB01

ATC

insulin (human); parenteral

2.2

35.2

306

1421

SPAT1310

SPAT

Counselling related to known health issue

1.3

35.2

2912

23424

C08DA01

ATC

verapamil; systemic

2.0

35.2

404

2082

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.7

35.2

719

4411

A29

ICPC

General symptom/complaint other

1.5

35.2

1349

9544

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

5.4

35.1

129

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.6

35.0

116

326

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.8

35.0

177

640

F34.1

ICD-10 Finland

Dysthymia

2.2

35.0

298

1373

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.2

34.9

298

1374

N06AB05

ATC

paroxetine; oral

1.8

34.9

502

2786

E000001, ,

ATC

1.4

34.9

1739

12911

K28.9

ICD-10 Finland

Gastrojejunal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

180.6

34.7

L12

ICPC

Hand/finger symptom/complaint

1.4

34.7

1555

11326

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

4.2

34.7

225

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.7

34.7

192

728

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

34.7

686

4173

E87.5

ICD-10 Finland

Hyperkalaemia

2.5

34.6

217

874

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

34.6

1706

12641

N05AH03

ATC

olanzapine; systemic

1.8

34.6

526

2970

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

34.4

697

4266

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.8

34.4

541

3086

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

34.3

834

5344

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

34.3

964

6390

K70.0

ICD-10 Finland

Alcoholic fatty liver

4.0

34.2

249

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.9

34.2

440

2357

E86

ICD-10 Finland

Volume depletion

2.3

34.1

271

1214

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

33.8

564

3272

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

33.7

3454

28577

UJD10, ,

SPAT

2.3

33.7

248

1075

P01

ICPC

Feeling anxious/nervous/tense

1.6

33.7

826

5303

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

33.7

783

4963

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

3.6

33.7

112

316

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.8

33.6

478

2643

207

Kela drug reimbursment

Chronic arrhythmias

1.4

33.6

1700

12645

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.7

33.6

683

4183

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

33.6

3545

29447

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

33.5

345

1710

K07.60

ICD-10 Finland

Snapping jaw

2.0

33.5

382

1964

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.5

33.4

113

322

J01DA06

ATC

[U] cefuroxime

1.5

33.4

1265

8921

SFA30

NOMESCO Finland

Three-surface restoration

1.3

33.4

3919

32995

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.9

33.3

154

531

N06AX12

ATC

bupropion; oral

1.8

33.2

510

2887

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

33.1

632

3808

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.2

33.1

279

1281

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.7

33.0

609

3634

Z00.0

ICD-10 Finland

General medical examination

1.4

33.0

1817

13710

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

32.9

631

3804

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.3

32.9

249

1092

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.0

32.9

384

1990

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

32.9

1178

8217

K83.0

ICD-10 Finland

Cholangitis

2.9

32.9

159

562

A03DA02

ATC

pitofenone and analgesics; systemic

2.5

32.7

202

808

U02

ICPC

Urinary frequency/urgency

1.4

32.7

1385

9975

ZY010

NOMESCO Finland

Hospital outpatient

1.9

32.7

400

2107

T89

ICPC

Diabetes insulin dependent

2.0

32.6

339

1687

SGA01

NOMESCO Finland

Emergency treatment

1.5

32.6

1297

9234

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

32.5

447

2445

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

32.5

527

3031

JN4BD

NOMESCO Finland

Extensive body CT

1.5

32.4

995

6719

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.0

32.4

373

1924

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.0

32.4

142

475

C08CA02

ATC

felodipine; oral

1.5

32.4

971

6525

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.8

32.3

523

3009

C08CA13

ATC

lercanidipine; oral

1.4

32.2

1475

10773

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.5

32.2

202

814

J45.8

ICD-10 Finland

Mixed asthma

2.2

32.2

286

1340

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

2.9

32.1

150

520

N06AA10

ATC

nortriptyline; systemic

2.6

32.1

189

739

SPAT1211

SPAT

Application of soft bandage

1.6

32.1

792

5090

UJC12

NOMESCO Finland

Flexible oesophagoscopy

4.7

32.1

159

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.8

32.1

495

2807

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

32.0

3949

33411

C09CA01

ATC

losartan; oral

1.3

31.9

2585

20678

J05AB01

ATC

aciclovir; systemic

1.4

31.9

1966

15097

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

31.8

1199

8443

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.9

31.8

240

K86.8

ICD-10 Finland

Other specified diseases of pancreas

6.1

31.8

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.7

31.7

609

3673

R01AD12

ATC

fluticasone furoate; nasal

1.3

31.7

2550

20374

I81

ICD-10 Finland

Portal vein thrombosis

5.3

31.7

119

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

31.7

1100

7620

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.2

31.7

206

I45.9

ICD-10 Finland

Conduction disorder, unspecified

3.4

31.7

112

329

ZXA10

NOMESCO Finland

Bilateral

1.4

31.7

1751

13210

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.8

31.6

446

2460

L04

ICPC

Chest symptom/complaint

1.7

31.6

573

3404

D07AA02

ATC

hydrocortisone; topical

1.5

31.5

1178

8282

K80.8

ICD-10 Finland

Other cholelithiasis

2.7

31.5

169

631

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.9

31.5

398

2120

M54

ICD-10 Finland

Dorsalgia

1.5

31.5

1025

7009

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

31.4

427

2329

D07AD01

ATC

clobetasol; topical

1.4

31.4

1530

11298

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

31.3

757

4841

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.0

31.3

327

1630

A08

ICPC

Swelling

1.7

31.3

578

3450

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

31.3

362

1871

5353A

ICD-9 Finland

Gastritis and duodenitis, Alcoholic gastritis

+∞

31.3

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

31.1

6113

54627

SPAT1216

SPAT

Assessment of functional ability

1.4

31.0

1532

11338

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

31.0

623

3805

R74

ICPC

Upper respiratory infection acute

1.3

30.9

2548

20416

A99

ICPC

Disease/condition unspecnature/site

1.5

30.8

992

6766

N06AX26

ATC

vortioxetine; oral

1.7

30.8

590

3557

R33

ICD-10 Finland

Retention of urine

1.6

30.8

827

5421

SPAT1312

SPAT

General health counselling

1.3

30.7

2803

22776

79199

ICD-8 Finland

Headache

2.8

30.7

149

528

H92.0

ICD-10 Finland

Otalgia

1.8

30.7

511

2963

JFB00

NOMESCO Finland

Partial resection of small intestine

2.6

30.7

176

680

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.6

30.6

274

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

30.6

1028

7071

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.9

30.6

138

R04.0

ICD-10 Finland

Epistaxis

1.6

30.6

764

4924

L05

ICPC

Flank/axilla symptom/complaint

1.7

30.6

588

3548

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

30.5

2002

15509

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

30.5

550

3262

K76.7

ICD-10 Finland

Hepatorenal syndrome

8.5

30.5

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

30.5

2615

21067

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

30.4

486

2785

F32.1

ICD-10 Finland

Moderate depressive episode

1.9

30.3

415

2268

JBC00

NOMESCO Finland

Gastro-oesophageal antireflux operation

51.6

30.3

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

30.2

2425

19352

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.8

30.2

451

2533

RD210, ,

NOMESCO Finland

2.8

30.1

153

556

R31

ICD-10 Finland

Unspecified haematuria

1.5

30.0

1040

7199

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.0

30.0

349

1807

E66.9

ICD-10 Finland

Obesity, unspecified

2.1

30.0

306

1512

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

30.0

663

4147

R06AX27

ATC

desloratadine; oral

1.3

29.9

2290

18146

V03AA01, ,

ATC

2.7

29.8

157

581

K04.08

ICD-10 Finland

Other specified pulpit

1.7

29.7

591

3598

R52.0

ICD-10 Finland

Acute pain

2.1

29.7

288

1397

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.3

29.7

226

995

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.2

29.6

259

1207

V03AE01

ATC

polystyrene sulfonate; oral

2.8

29.6

148

533

SPAT1236

SPAT

Informing family of child’s disability

2.4

29.6

205

866

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

29.5

1332

9698

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

29.4

423

2347

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.4

29.4

201

844

N07BA03

ATC

varenicline; oral

1.9

29.3

396

2154

I95.9

ICD-10 Finland

Hypotension, unspecified

2.6

29.3

173

678

I78.8

ICD-10 Finland

Other diseases of capillaries

6.6

29.3

M05BA04

ATC

alendronic acid; oral

1.5

29.3

857

5724

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.1

29.3

201

D07AB08

ATC

desonide; topical

1.5

29.2

969

6646

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.5

29.2

183

738

53094

ICD-8 Finland

Diseases of oesophagus, Oesophagitis

+∞

29.2

M54.8

ICD-10 Finland

Other dorsalgia

1.9

29.1

395

2152

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.3

29.0

109

333

XKD00

NOMESCO Finland

Uroflowmetry

1.4

29.0

1567

11762

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

2.5

29.0

178

711

G04BD08

ATC

solifenacin; oral

1.6

28.9

619

3840

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

28.9

826

5487

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.3

28.9

212

918

WX290

NOMESCO Finland

Other blockage of nerve

1.3

28.9

3989

34090

L86

ICPC

Back syndrome with radiating pain

1.7

28.9

567

3439

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

28.8

722

4654

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

28.8

976

6722

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.7

28.8

611

3782

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.3

28.8

212

920

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.3

28.7

108

330

B05DA

ATC

Isotonic solutions

3.9

28.7

217

D15

ICPC

Melaena

5.2

28.7

115

S20.2

ICD-10 Finland

Contusion of thorax

1.8

28.7

483

2809

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

28.7

386

2098

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

28.7

2122

16719

A12BA01

ATC

potassium chloride; oral

1.8

28.6

442

2506

EB1VA, ,

NOMESCO Finland

1.4

28.6

1550

11635

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

28.6

1909

14810

JKA20

NOMESCO Finland

Cholecystectomy

2.1

28.6

268

1283

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.2

28.6

112

351

C01AA05

ATC

digoxin; systemic

1.5

28.5

845

5660

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

28.2

1747

13395

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.1

28.2

115

369

M43.1

ICD-10 Finland

Spondylolisthesis

1.9

28.2

366

1967

XG466

NOMESCO Finland

Sleep oxymetry

2.1

28.2

277

1351

U01

ICPC

Dysuria/painful urination

1.6

28.1

686

4394

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

6.4

28.1

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.3

28.0

210

918

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

28.0

1236

8954

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.9

28.0

127

434

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.3

27.9

211

926

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

27.9

6328

57129

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.9

27.9

350

1860

C09CA06

ATC

candesartan; oral

1.3

27.8

2248

17922

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

27.8

478

2797

C10AA03

ATC

pravastatin; oral

1.6

27.8

697

4495

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

27.7

593

3678

L84

ICD-10 Finland

Corns and callosities

1.9

27.7

337

1772

A07EA02

ATC

hydrocortisone; rectal

2.4

27.7

188

787

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.9

27.7

205

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

27.7

449

2584

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

27.6

309

1580

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.1

27.5

267

1296

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.4

27.5

191

808

L04AB04

ATC

adalimumab; parenteral

2.4

27.5

187

784

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.4

27.4

181

748

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

3.4

27.4

100

300

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

27.4

2070

16347

B05DB

ATC

Hypertonic solutions

4.0

27.3

198

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.1

27.3

112

361

C10AA04

ATC

fluvastatin; oral

1.5

27.3

851

5760

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

27.3

1051

7423

R30.0

ICD-10 Finland

Dysuria

1.9

27.3

366

1988

JF1BD

NOMESCO Finland

Very extensive small bowel CT

4.7

27.2

132

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.0

27.1

280

1390

5301X

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[OESOPHAGITIS NUD]

+∞

27.1

WW500

NOMESCO Finland

Blood transfusion

1.9

27.0

371

2029

C02AC05

ATC

moxonidine; oral

1.8

27.0

447

2586

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

27.0

1583

12030

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.1

27.0

113

369

R25.2

ICD-10 Finland

Cramp and spasm

2.2

26.9

228

1049

K57.1

ICD-10 Finland

Diverticular disease of small intestine without perforation or abscess

2.7

26.9

143

532

SPAT1139

SPAT

Nutrition survey

2.0

26.9

315

1636

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.3

26.8

158

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

26.8

1210

8798

N05AF03

ATC

chlorprothixene; systemic

2.2

26.8

223

1019

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.4

26.8

189

805

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.3

26.8

206

911

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

26.8

1327

9808

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.5

26.8

163

649

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.8

26.8

407

2298

R52.1

ICD-10 Finland

Chronic intractable pain

3.4

26.6

281

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

3.3

26.6

301

R95

ICPC

Chron obstructive pulmonary disease

2.0

26.6

304

1566

C08DB01

ATC

diltiazem; oral

1.7

26.5

511

3084

Z49.2

ICD-10 Finland

Other dialysis

3.8

26.5

216

I86.4

ICD-10 Finland

Gastric varices

24.7

26.5

Z72.1

ICD-10 Finland

Alcohol use

2.9

26.5

120

410

A10AB04

ATC

insulin lispro; parenteral

2.1

26.4

258

1255

SAA04

NOMESCO Finland

Special examination of mouth

1.8

26.4

422

2417

K85.8

ICD-10 Finland

Other acute pancreatitis

3.8

26.3

213

K65.0

ICD-10 Finland

Acute peritonitis

2.9

26.2

119

407

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

26.2

665

4300

M01AB08

ATC

etodolac; oral

1.6

26.2

629

4015

N41.1

ICD-10 Finland

Chronic prostatitis

2.2

26.1

224

1036

L01BA01

ATC

methotrexate; systemic

1.9

26.1

327

1737

5322A

ICD-9 Finland

Duodenal ulcer, Acute with haemorrhage and perforation[ULCUS BULBI,KOMPLISOITUMATON]

+∞

26.0

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.3

26.0

202

897

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.4

26.0

180

761

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.0

26.0

287

1461

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.9

25.9

118

404

Z00.8

ICD-10 Finland

Other general examinations

1.6

25.9

703

4615

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.8

25.9

404

2298

D12

ICPC

Constipation

1.9

25.9

352

1920

I49.5

ICD-10 Finland

Sick sinus syndrome

1.8

25.9

397

2248

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

3.3

25.8

297

L14

ICPC

Leg/thigh symptom/complaint

1.5

25.7

749

4996

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

25.7

875

6030

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.2

25.7

212

966

R03BB01

ATC

ipratropium bromide; inhalant

1.8

25.6

365

2020

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.9

25.5

322

1714

I50.1

ICD-10 Finland

Left ventricular failure

1.7

25.5

509

3100

K29

ICD-10 Finland

Gastritis and duodenitis

5.3

25.5

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.0

25.5

290

1491

D25

ICPC

Abdominal distension

2.4

25.5

180

768

R09.1

ICD-10 Finland

Pleurisy

2.5

25.4

160

647

SPAT1153

SPAT

Removal of sutures

1.3

25.4

2939

24508

A10AE06

ATC

insulin degludec; parenteral

1.9

25.3

303

1585

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

25.3

1062

7618

M01AH03

ATC

valdecoxib; oral

1.6

25.3

535

3309

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.0

25.2

282

1441

A41.9

ICD-10 Finland

Sepsis, unspecified

1.9

25.2

347

1901

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

25.2

799

5427

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

6.4

25.1

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

25.1

476

2861

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.3

25.1

292

S80.0

ICD-10 Finland

Contusion of knee

1.6

25.0

618

3969

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.1

25.0

171

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.1

25.0

240

1161

B01AC07

ATC

dipyridamole; systemic

1.7

25.0

432

2532

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

25.0

1045

7491

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

25.0

322

1727

SPAT1081

SPAT

Cardiorespiratory global assessment

1.7

25.0

518

3188

P16

ICPC

Acute alcohol abuse

2.7

24.9

136

513

N06AG02

ATC

moclobemide; oral

1.8

24.9

374

2103

A10AA02, ,

ATC

2.0

24.9

286

1475

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

24.9

830

5693

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

24.9

543

3384

I50

ICD-10 Finland

Heart failure

1.9

24.9

324

1743

196

Kela drug reimbursment

Paricalcitol and cinacalcet

4.6

24.9

130

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

2.9

24.9

116

403

WZC30

NOMESCO Finland

Teaching

1.4

24.7

1543

11825

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.5

24.7

154

620

JAD10

NOMESCO Finland

Repair of incisional hernia

3.5

24.7

241

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

24.7

806

5505

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

5.6

24.7

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

3.0

24.7

108

362

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.7

24.7

413

2399

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.6

24.6

547

3424

A07DA03

ATC

loperamide; oral

1.9

24.6

317

1699

A04AA01

ATC

ondansetron; systemic, rectal

1.5

24.6

749

5041

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

24.6

835

5748

SFA00

NOMESCO Finland

Small restoration

1.4

24.6

1199

8829

I95.1

ICD-10 Finland

Orthostatic hypotension

1.8

24.6

403

2326

S29

ICPC

Skin symptom/complaint other

1.3

24.6

1905

15068

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

24.6

3818

32903

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.9

24.5

310

1653

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

24.5

882

6145

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

24.5

195

876

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

3.0

24.5

109

369

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.3

24.4

184

808

K51.8

ICD-10 Finland

Other ulcerative colitis

2.8

24.3

124

452

D01AC02

ATC

miconazole; topical

1.5

24.3

688

4559

N06AA06

ATC

trimipramine; systemic

2.2

24.3

209

969

M01AX05

ATC

glucosamine; oral

1.3

24.2

1841

14518

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6246

42006

2.11

311.79

4.6

2.9

125.08

145.02

ug/l

7.82

5906

38876

(3024561) Albumin [Mass/volume] in Serum or Plasma

6570

44435

2.16

307.65

7.8

4.8

34.87

35.33

g/l

8.63

6271

41476

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5425

28934

2.70

307.65

4.0

2.5

72.37

63.50

u/l

0.29

5125

26649

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7599

50270

2.60

307.65

9.0

6.5

12.20

11.94

umol/l

0.73

7312

47844

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

305

110

28.48

307.65

1.1

1.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3048

14453

2.53

307.65

3.7

2.5

21.18

22.52

6.00

2870

13372

(3013139) Helicobacter pylori Ag [Presence] in Stool

1558

5124

3.37

307.65

1.4

1.2

—

(40768797) Stomach Pathology biopsy report

4002

8595

6.70

307.65

1.4

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

2318

10059

2.65

307.65

3.1

2.2

150.36

138.87

ug/g

0.79

1932

7942

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3238

15613

2.51

307.65

3.6

2.5

2.34

2.28

g/l

6.69

3038

14402

(3022948) Iron [Moles/volume] in Serum or Plasma

3393

16660

2.49

307.65

3.7

2.5

12.07

12.82

umol/l

6.93

3209

15469

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4621

24852

2.47

307.65

3.3

2.2

3.14

2.83

mg/l

12.41

4183

21329

(3013115) Eosinophils [#/volume] in Blood

6954

49412

2.08

290.17

8.8

6.3

0.19

e9/l

0.01

6283

42473

(3006315) Basophils [#/volume] in Blood

6805

48039

2.07

288.17

8.5

6.1

0.04

e9/l

2.53

6090

40585

(3001604) Monocytes [#/volume] in Blood

6784

47884

2.06

286.77

8.5

6.1

0.61

0.60

e9/l

2.52

6075

40432

(3007164) IgA [Mass/volume] in Serum or Plasma

3117

16469

2.24

286.56

1.7

1.5

2.75

2.49

g/l

6.80

1994

9955

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3410

18776

2.18

282.01

1.4

1.3

1.95

1.79

u/ml

0.23

881

5093

(3019198) Lymphocytes [#/volume] in Blood

6866

48962

2.05

278.38

8.6

6.2

1.87

1.90

e9/l

0.57

6244

42403

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2052

9134

2.53

278.29

3.1

2.1

0.20

0.21

g/l

1.77

1916

8499

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

891

2470

3.83

276.68

1.7

1.6

26.30

18.73

u/ml

1.71

167

607

(3032080) INR in Blood by Coagulation assay

6624

46693

2.03

276.66

20.4

16.3

1.31

1.30

inr

0.76

5699

38939

(3022145) Colonoscopy Study observation

2197

10171

2.44

273.21

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9162

73266

2.40

271.80

12.9

8.0

83.47

80.05

u/l

7.72

8863

69306

(3027945) Reticulocytes/Erythrocytes in Blood

2379

11624

2.33

260.49

2.8

2.4

1.91

1.76

7.11

2156

10363

(3013650) Neutrophils [#/volume] in Blood by Automated count

7298

54050

2.01

255.12

11.7

9.6

4.24

4.21

e9/l

0.45

6572

46263

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6369

45016

1.97

255.00

9.8

6.4

1.20

1.21

mmol/l

8.03

6001

41554

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6917

50394

1.98

252.10

10.5

7.0

1.21

mmol/l

8.21

6124

43240

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4754

30597

1.96

249.15

4.8

3.2

38.60

34.99

u/l

0.45

4506

28774

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2181

10534

2.33

243.63

4.1

2.6

9.64

9.27

umol/l

0.25

1926

9249

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1603

6880

2.55

231.56

2.0

1.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6126

43684

1.89

228.15

2.7

2.1

94.00

95.16

pmol/l

1.13

3556

23004

(3028026) IgM [Mass/volume] in Serum or Plasma

1328

5245

2.74

226.65

2.0

1.36

1.33

g/l

0.19

1231

4783

(3019069) Monocytes/Leukocytes in Blood

6178

44246

1.89

226.21

8.9

6.4

9.11

8.97

3.31

5887

41329

(3006504) Eosinophils/Leukocytes in Blood

6161

44102

1.89

225.76

8.8

6.3

2.84

2.83

0.13

5869

41177

(3018010) Neutrophils/Leukocytes in Blood

6162

44165

1.88

224.32

8.7

6.2

58.17

57.89

1.09

5943

42109

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5422

37327

1.88

223.91

5.6

3.7

35.95

77.91

ng/l

2.50

4140

27374

(3002030) Lymphocytes/Leukocytes in Blood

6252

45204

1.87

219.37

8.8

6.3

26.58

27.02

2.44

6010

42652

(3013826) Glucose [Moles/volume] in Serum or Plasma

7489

57412

1.93

218.41

7.9

4.9

6.92

6.77

mmol/l

7.02

7246

54533

(3022096) Basophils/Leukocytes in Blood

6136

44151

1.87

218.13

8.9

6.4

0.70

0.67

3.71

5837

41210

(3005719) IgG [Mass/volume] in Serum or Plasma

1547

6760

2.50

214.03

2.9

10.94

10.58

g/l

2.18

1446

6241

(3037522) Nuclear Ab [Titer] in Serum

2332

12175

2.16

212.23

1.5

1.3

548.31

483.43

titre

0.81

503

2554

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

8587

69296

2.04

211.09

6.2

4.2

14.87

12.97

mm/h

21.32

8181

64501

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1182

4558

2.78

210.57

1.9

1.6

1.49

1.57

g/l

1.78

1039

3885

(3019309) Folate [Moles/volume] in Red Blood Cells

2962

16999

2.01

208.35

1.9

1.7

1162.66

1167.68

nmol/l

0.10

2380

12702

(3023520) Reticulocytes [#/volume] in Blood

1874

9041

2.29

206.77

2.8

2.5

72.85

68.54

e9/l

4.21

1407

6596

(3031040) Bacteria [#/volume] in Urine by Automated count

7956

62940

1.92

201.80

6.7

4.7

726.68

2192.93

e6/l

2.80

993

(3007566) Smooth muscle Ab [Titer] in Serum

760

2329

3.43

201.52

1.3

1.2

72.46

157.78

titre

2.27

221

(3023368) Bacteria identified in Blood by Culture

4337

28515

1.85

200.62

5.8

4.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

660

1881

3.67

195.45

4.3

2.2

38.15

32.71

umol/l

5.09

615

1664

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4577

30794

1.82

194.88

2.8

2.2

184.41

221.70

u/l

2.76

4384

28962

(3034770) Mitochondria Ab [Titer] in Serum

749

2335

3.37

193.10

1.3

1.2

702.14

941.67

titre

0.64

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4631

31359

1.82

192.27

4.0

3.1

1726.53

1499.33

ng/l

2.25

4094

27218

(3021960) Folate [Moles/volume] in Serum or Plasma

4324

28697

1.83

191.71

2.0

1.7

20.01

20.06

nmol/l

0.09

3818

24186

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2381

12985

2.06

190.68

8.8

5.6

1.06

1.04

mmol/l

3.80

2264

12029

(3000570) Elastase.pancreatic [Mass/mass] in Stool

783

2556

3.22

187.13

1.5

1.4

279.51

269.07

ug/g

0.63

479

1537

(3002032) Base excess in Venous blood by calculation

1942

9900

2.16

185.29

5.5

3.8

1.54

1.81

mmol/l

2.41

1700

8647

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2195

11747

2.08

184.28

4.2

4.6

234.38

248.14

u/l

5.06

2064

11133

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3257

20068

1.88

181.06

2.1

1.7

1.28

1.35

mg/l

0.47

2607

15776

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1977

10234

2.13

180.93

5.4

3.7

5.76

5.81

kpa

1.70

1933

9976

(3015736) pH of Urine

5599

40563

1.76

180.89

4.7

3.5

6.28

6.22

3.51

3220

22013

(3012544) pH of Venous blood

1985

10339

2.12

178.53

5.5

3.7

7.38

0.06

1219

5875

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1760

8809

2.18

175.08

3.7

2.3

36.83

48.13

u/l

0.74

1521

7422

(3018418) pH of Serum or Plasma

4493

30764

1.77

174.84

6.2

4.1

7.40

0.86

3452

21883

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2796

16597

1.91

173.09

4.2

3.2

0.80

0.82

mmol/l

16.49

2656

15590

(3009261) Glucose [Presence] in Urine by Test strip

6688

51563

1.74

167.91

5.4

3.9

0.05

0.36

estimate

1.13

1318

10460

(3020779) Urea [Moles/volume] in Serum or Plasma

1779

9100

2.14

166.72

11.0

6.8

11.01

10.37

mmol/l

2.85

1718

8653

(3037467) Urinalysis macro (dipstick) panel - Urine

7989

64930

1.81

165.66

6.5

4.5

2.34

2.09

0.13

100

(3021601) Nitrite [Presence] in Urine by Test strip

6574

50595

1.73

164.53

5.4

3.9

0.00

estimate

0.35

1376

10806

(3042936) Bacteria identified in Isolate by Culture

2428

13978

1.94

163.51

2.6

2.0

—

(3035350) Ketones [Presence] in Urine by Test strip

6629

51206

1.73

162.99

5.4

3.9

3.93

4.40

estimate

0.08

1387

11148

(3017143) Hepatitis C virus Ab [Presence] in Serum

1767

9090

2.12

162.86

1.8

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

1680

8551

2.14

158.88

4.4

3.1

4.55

4.48

kpa

0.62

1637

8318

(3014111) Lactate [Moles/volume] in Serum or Plasma

1762

9209

2.08

155.09

8.9

7.3

1.40

1.34

mmol/l

1.46

1726

9024

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1264

5796

2.33

154.14

5.6

3.9

23.93

24.22

mmol/l

2.60

1246

5728

(36304419) Bacteria [Presence] in Urine

3975

27003

1.73

153.75

4.1

3.2

0.85

253.67

estimate

0.57

120

(3000991) Gas panel - Venous blood

1701

8809

2.10

153.29

11.0

8.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7414

59630

1.73

151.72

5.2

3.1

66.74

50.03

u/l

25.33

7038

55506

(3002582) Erythrocytes [#/volume] in Urine

4649

33057

1.70

151.41

4.4

3.4

91.45

95.32

e6/l

0.04

3761

25137

(3007853) Bacteria identified in Skin by Aerobe culture

2012

11180

1.98

148.74

2.1

1.8

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2136

12191

1.93

145.60

8.9

7.3

11.96

12.37

kpa

3.16

2055

11718

(3019977) pH of Arterial blood

2133

12173

1.93

145.41

9.0

7.3

7.42

0.83

1208

6570

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2136

12196

1.93

145.40

8.9

7.3

5.03

5.10

kpa

3.02

2056

11743

(3030467) Casts [#/volume] in Urine by Automated count

4113

28566

1.70

144.34

4.3

3.3

0.47

0.46

e6/l

0.04

3227

20899

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2748

17034

1.81

144.16

2.3

1.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5854

44585

1.66

143.74

3.7

2.7

—

estimate

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1613

8377

2.08

143.54

2.6

2.4

363.88

384.20

nmol/l

3.64

1504

7757

(3044640) Blood type and Crossmatch panel - Blood

4388

31088

1.68

142.27

3.4

2.4

—

(3003396) Base excess in Arterial blood by calculation

2111

12093

1.92

141.90

9.0

7.2

0.76

0.94

mmol/l

1.10

1766

9995

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5686

43160

1.65

140.00

3.2

2.3

75.98

78.41

nmol/l

8.65

5214

38806

(3000850) Epithelial cells [#/volume] in Urine

3421

22748

1.73

139.93

3.4

2.7

5.14

5.32

e6/l

0.35

3160

20707

(44816559) Phosphatidylethanol [Mass/volume] in Blood

838

3323

2.65

139.34

2.2

1.6

0.37

0.31

mg/l

2.14

411

1553

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2016

11437

1.93

139.27

1.8

1.6

—

(3016502) Oxygen saturation in Arterial blood

1938

10870

1.95

138.41

9.3

7.6

95.60

95.44

0.53

1883

10501

(3018095) Leukocytes [#/volume] in Urine

5037

37172

1.65

137.98

5.3

4.0

99.52

108.91

e6/l

0.22

3854

26192

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2980

19275

1.75

133.38

5.4

3.8

272.99

491.26

ng/l

2.46

2444

15723

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2167

12778

1.86

132.14

2.2

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3475

23679

1.68

127.22

5.0

3.8

0.31

0.38

0.11

274

(40758558) Short blood count panel - Blood

4089

29071

1.64

126.71

8.3

6.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3726

25912

1.66

125.75

3.4

2.7

357.93

347.91

umol/l

6.24

3299

22656

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3446

23495

1.68

125.52

3.3

2.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2487

15512

1.78

125.14

2.5

2.1

30.02

29.74

1.34

2425

15111

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1002

4545

2.32

124.13

2.8

2.3

—

(3033658) Prothrombin time (PT) actual/Normal

3573

24705

1.66

122.64

7.1

3.9

86.41

87.75

2.24

3484

24198

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2029

12009

1.84

121.09

2.3

1.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1429

7534

2.03

120.57

5.2

3.7

102.43

90.67

ng/l

3.74

1258

6439

(3020630) Protein [Mass/volume] in Serum or Plasma

1593

8730

1.96

120.35

2.6

2.7

65.72

66.23

g/l

1.73

1455

7927

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1689

9448

1.93

120.06

2.3

1.7

1.68

1.48

14.76

1481

8187

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2739

17853

1.71

116.58

3.6

3.0

1.12

1.34

e6/l

0.59

1633

9455

(3019150) Specific gravity of Urine by Refractometry

3246

22152

1.66

115.89

5.7

4.2

1.02

1.22

kg/l

1.06

2323

14705

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1761

10107

1.88

115.32

10.0

8.0

118.07

121.41

g/l

8.92

1733

9882

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8303

70890

1.67

115.30

5.2

4.3

14.93

14.88

pmol/l

0.94

7710

64649

(3015377) Calcium [Moles/volume] in Serum or Plasma

4601

34434

1.57

110.66

3.7

3.6

2.35

2.36

mmol/l

6.50

4241

31250

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1522

8508

1.91

107.48

2.9

2.3

6.08

7.71

ug/l

2.91

1325

7417

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

708

2948

2.50

105.68

1.4

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

377

1130

3.42

102.69

1.1

1.58

1.52

g/l

2.06

341

1030

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

509

1853

2.83

99.31

6.8

4.5

491.89

1695.82

iu/ml

0.69

104

238

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1057

5374

2.07

97.42

4.1

2.9

1.40

1.20

6.35

1052

5348

(3014051) Protein [Presence] in Urine by Test strip

3642

26404

1.56

97.33

3.8

3.0

0.04

0.07

0.81

732

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2460

16234

1.66

97.21

1.4

1.3

33.99

35.69

iu/ml

0.20

755

4921

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4903

37976

1.52

96.44

5.5

3.9

0.28

0.45

estimate

0.37

1149

8824

(3025941) Bacteria identified in Stool by Culture

914

4447

2.15

94.48

1.4

1.2

—

(3019060) Gas panel - Arterial blood

1156

6158

1.98

93.35

5.3

4.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

792

3655

2.26

93.34

1.2

1.1

252.75

189.42

titre

0.20

106

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

558

2203

2.61

92.87

1.5

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2965

20701

1.59

92.34

1.9

1.7

36142180.89

25658249.24

pmol/l

0.42

2540

16950

(36660697) Celiac disease serology panel - Serum

1205

6544

1.94

91.91

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

644

2738

2.43

91.63

1.8

1.6

—

(3026782) Osmolality of Urine

2799

19335

1.60

90.96

3.6

2.9

511.99

535.87

mosm/kgh2o

6.92

2501

16932

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2290

15107

1.65

89.60

1.4

1.3

8.17

12.62

u/ml

2.90

803

5795

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

782

3650

2.23

89.56

2.2

556.08

648.22

ug/l

0.38

745

3466

(3021589) Normoblasts [#/volume] in Blood

5356

42705

1.49

88.82

16.5

11.6

0.00

e9/l

0.31

4556

34612

(3004119) Hemoglobin [Mass/volume] in Venous blood

1160

6309

1.94

87.88

4.3

3.3

123.95

129.29

g/l

11.88

1136

6134

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

990

5102

2.03

87.54

1.6

1.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1239

6917

1.89

86.65

11.5

9.0

1.44

1.31

4.15

1232

6882

(3009508) Creatinine [Moles/volume] in Urine

4523

34999

1.49

86.14

4.1

3.4

7.04

7.46

mmol/l

8.92

3915

29363

(3038177) Helicobacter pylori Ab [Presence] in Serum

345

1094

3.22

85.75

1.4

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

549

2239

2.53

85.34

1.2

1.1

—

(3012516) Albumin [Mass/volume] in Urine

4356

33539

1.49

84.55

4.1

3.4

68.60

46.19

mg/l

6.08

3026

21429

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1710

10609

1.72

83.80

3.7

4.5

26.43

29.64

ug/l

0.14

1430

8809

(3014765) Yersinia sp identified in Stool by Organism specific culture

549

2260

2.50

83.65

1.2

1.1

—

(3017732) Neutrophils [#/volume] in Blood

1848

11726

1.69

83.30

3.1

3.2

5.11

4.57

e9/l

1.19

1593

10112

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

989

5183

2.00

83.27

5.3

3.8

47.43

46.98

0.22

978

5104

(46235355) HIV 1 and 2 tests - Meaningful Use set

2024

13155

1.66

83.21

2.0

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

4415

34179

1.48

82.90

4.8

4.1

13.66

8.30

mg/mmol

6.56

2953

21189

(42529406) Shigella sp [Presence] in Stool by Culture

549

2271

2.49

82.77

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1155

6407

1.90

82.15

8.4

6.7

24.48

24.54

mmol/l

0.22

1123

6143

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

752

3590

2.17

81.23

3.3

3.6

1191.33

2416.50

u/ml

0.63

657

3106

(3026250) Tacrolimus [Mass/volume] in Blood

163

310

5.32

81.01

41.8

38.1

6.99

7.25

ug/l

0.68

152

275

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1148

6388

1.89

80.81

4.3

3.6

5.15

kpa

0.03

1108

6057

(3029937) Albumin [Presence] in Urine by Test strip

3786

28565

1.49

80.04

5.7

4.1

0.00

estimate

0.67

1250

9853

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1006

5387

1.95

79.44

4.1

3.5

1.79

1.92

mmol/l

0.50

724

3954

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2384

16296

1.59

79.30

3.8

3.1

2.55

2.43

e6/l

0.23

1284

7870

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

592

2584

2.36

79.23

1.4

1.3

—

(40761535) Cells panel - Urine sediment

1284

7447

1.82

79.09

4.4

3.4

—

0.80

—

(3009343) pH of Capillary blood

1114

6191

1.89

78.62

4.3

3.6

7.41

7.42

1.75

958

5121

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9925

91400

1.78

77.03

30.1

16.2

23.48

26.30

mg/l

16.30

8952

75634

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1113

6237

1.87

76.44

2.0

1.7

—

(3000494) Fungus identified in Specimen by Culture

1751

11206

1.67

75.70

1.6

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1118

6295

1.86

75.59

10.9

8.9

24.10

24.31

mmol/l

1.22

1083

6147

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1105

6201

1.87

75.51

1.5

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

813

4111

2.05

75.37

1.5

1.6

10.54

16.97

iu/ml

0.46

111

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1369

8205

1.76

75.23

3.6

2.9

221.31

210.19

ng/l

0.42

1274

7542

(3023487) Leukocytes [#/volume] in Peritoneal fluid

166

344

4.88

74.79

2.6

1.8

357.71

5054.82

e6/l

1.01

121

226

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

584

2602

2.31

74.48

1.4

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2836

20416

1.52

73.97

6.4

4.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

733

3605

2.11

73.15

1.8

1.7

7.66

6.96

iu/ml

0.18

176

822

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

712

3472

2.12

72.65

1.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

242

683

3.60

72.27

1.2

326.00

160.00

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

242

683

3.60

72.27

1.2

147.50

176.16

titre

0.25

112

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1165

6746

1.81

71.76

10.1

7.7

24.57

24.80

mmol/l

1.18

1157

6692

(3020891) Body temperature

909

4890

1.94

70.50

6.6

4.3

36.93

36.90

°c

1.09

901

4842

(3026692) Albumin [Mass/volume] in Peritoneal fluid

137

253

5.47

70.36

1.6

1.3

11.29

14.49

g/l

3.29

101

192

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

814

4219

2.00

70.33

2.3

2.4

3.79

3.72

g/l

0.54

739

3837

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

815

4231

2.00

70.08

2.3

2.4

7.50

7.40

g/l

0.90

737

3849

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

814

4226

2.00

69.99

2.3

2.4

4.17

4.19

g/l

0.27

738

3850

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1316

7955

1.74

69.85

3.5

2.7

59.99

64.43

ml/min/173m2

3.31

574

3326

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

583

2668

2.25

69.71

2.8

2.5

3.54

3.63

g/l

0.75

566

2554

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

385

1459

2.70

69.38

2.9

2.4

128.14

1546.81

u/ml

1.46

(3013512) EKG study

4323

34229

1.43

67.80

4.8

3.6

0.71

0.75

0.11

(3027273) Bicarbonate [Moles/volume] in Venous blood

852

4577

1.93

66.22

4.5

3.3

24.91

25.16

mmol/l

1.17

834

4421

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

177

426

4.21

66.17

2.9

1.9

86.89

97.42

2.53

172

409

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

721

3664

2.03

65.71

2.3

2.4

10.33

10.26

g/l

0.14

638

3243

(3042733) HLA Ab [Presence] in Serum

122

216

5.70

65.56

3.8

5.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

372

1428

2.66

65.34

1.8

1.6

0.67

0.86

g/l

3.74

304

1102

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

765

3984

1.99

65.07

2.3

2.4

3.01

2.93

g/l

1.47

688

3601

(40768804) Tissue Pathology biopsy report

4685

37824

1.41

64.93

2.4

2.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

720

3675

2.03

64.81

2.4

2.5

0.74

0.93

g/l

0.66

621

3137

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

9302

85056

1.56

64.41

6.7

5.2

1.91

1.97

mu/l

4.99

8728

78096

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

748

3889

1.99

63.90

1.1

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

142

296

4.85

63.57

2.5

1.6

3156.86

12986.42

e6/l

1.35

158

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

791

4204

1.95

63.38

1.1

4.38

9.19

u/ml

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

577

2740

2.17

62.87

1.7

1.6

1.17

1.20

g/l

1.35

547

2613

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

563

2650

2.18

62.73

1.7

1.6

0.24

g/l

0.13

535

2519

(3044007) Cell count panel - Peritoneal fluid

139

288

4.87

62.68

2.6

1.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

214

613

3.54

62.52

1.1

1.0

287.32

289.06

mg/l

0.12

192

562

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

628

3109

2.08

61.38

2.3

2.4

0.01

0.04

g/l

1.96

561

2786

(3018405) Lactate [Moles/volume] in Arterial blood

663

3358

2.04

60.89

5.3

3.9

1.44

1.40

mmol/l

0.31

651

3299

(3034860) Kappa light chains.free [Mass/volume] in Serum

705

3655

1.99

60.64

3.0

3.3

57.30

54.25

mg/l

0.29

608

3063

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

610

3008

2.09

60.23

2.3

2.4

0.00

g/l

1.04

535

2618

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

701

3653

1.98

59.39

3.0

3.3

50.03

43.27

mg/l

0.51

605

3062

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

576

2798

2.12

59.16

2.4

2.5

0.00

g/l

-0.00

535

2613

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

566

2734

2.13

58.99

1.5

26.15

4.28

iu/ml

0.41

130

545

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1010

5941

1.77

58.44

10.8

9.4

15.63

16.05

2.97

981

5736

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1161

7104

1.71

58.37

1.6

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

448

1976

2.32

58.36

1.3

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

214

647

3.35

57.50

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

905

5179

1.81

57.42

1.5

1.3

259.56

272.32

u/ml

0.13

837

4794

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

765

4167

1.90

56.78

2.2

1.9

2.43

2.06

ug/l

0.28

691

3683

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

635

3273

2.00

55.44

3.0

3.2

2.15

4.12

ratio

1.63

390

1859

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

424

1869

2.32

55.30

1.1

12.80

8.29

eliau/ml

0.34

215

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2733

20510

1.44

54.82

3.2

3.1

2.46

mmol/l

0.30

2429

18474

(3004716) Salmonella sp identified in Stool by Organism specific culture

682

3618

1.94

54.77

1.3

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

544

2682

2.08

53.66

1.5

1.4

27.31

17.44

iu/ml

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

366

1536

2.43

53.34

1.5

1.4

154.53

154.20

au/ml

0.01

469

(3015235) Bicarbonate [Moles/volume] in Capillary blood

650

3441

1.94

52.48

3.4

3.0

24.76

mmol/l

0.00

637

3379

(3024471) HLA-A [Type]

109

214

5.13

52.36

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

109

214

5.13

52.36

1.5

1.4

21.81

27.98

g/l

3.16

174

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

345

1424

2.47

52.13

1.1

—

(3024932) HLA-DR beta [Type]

107

208

5.18

51.98

1.0

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5976

51317

1.35

51.90

3.1

2.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

482

2299

2.15

51.84

1.3

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

388

1695

2.34

51.66

1.5

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

140

341

4.15

51.58

34.1

27.2

112.10

107.91

ug/l

0.34

120

281

(3036489) Thrombin time

641

3416

1.93

50.72

2.3

2.0

21.77

21.14

1.09

585

3062

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

132

313

4.26

50.40

3.6

2.5

0.59

0.62

mmol/l

3.03

132

313

(3016650) Hepatitis A virus Ab [Presence] in Serum

341

1422

2.44

50.39

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

506

2516

2.06

48.74

2.7

2.4

210.35

197.98

2.01

484

2404

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

431

2018

2.18

48.57

1.3

1.2

8.01

4.64

u/ml

0.21

126

(3037756) Immunofixation for Serum or Plasma

461

2217

2.13

48.52

1.5

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

535

2720

2.02

48.47

2.4

2.2

87.94

91.94

3.05

523

2630

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

355

1537

2.35

48.25

1.4

1.2

317.37

261.11

u/ml

1.88

236

962

(3026389) Candida sp identified in Specimen by Organism specific culture

305

1233

2.52

48.19

1.5

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

636

3461

1.89

47.17

2.9

2.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

627

3398

1.90

47.10

1.3

1.2

0.81

0.72

u/ml

0.06

289

(3024928) Oxygen saturation in Venous blood

498

2494

2.04

47.03

3.9

3.2

63.02

61.09

1.02

473

2418

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

506

2549

2.03

47.02

1.4

1.2

39.75

45.39

u/ml

0.15

133

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

481

2379

2.07

47.00

1.4

1.3

4.48

3.36

u/ml

0.50

207

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

698

3925

1.83

46.65

2.1

1.9

41.40

39.38

u/l

1.48

623

3434

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1265

8378

1.58

45.74

2.9

2.5

0.43

0.45

e6/l

0.17

1226

8040

(3022313) Gas panel - Capillary blood

740

4262

1.79

45.66

4.4

3.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

477

2379

2.05

45.55

1.4

1.3

6.71

6.24

u/ml

0.07

327

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

552

2906

1.95

45.22

2.2

1.7

—

(3017181) Myelocytes/Leukocytes in Blood

1337

9002

1.55

44.90

5.0

4.2

1.02

0.94

0.42

478

2714

(3045414) Leukocytes [Presence] in Urine

1379

9350

1.54

44.86

2.4

2.1

0.01

0.02

estimate

0.49

261

1863

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

244

918

2.70

44.64

1.2

1.1

6.15

3.42

eliau/ml

0.75

411

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

445

2191

2.07

44.00

1.3

1.2

59.86

9.34

u/ml

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

10010

94605

1.57

43.65

34.6

19.5

139.35

139.70

mmol/l

33.85

9914

92678

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

158

471

3.39

43.50

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

159

477

3.37

43.34

1.3

1.2

—

(3022621) pH of Urine by Test strip

1146

7524

1.58

42.88

3.5

2.7

5.98

6.06

2.07

807

5279

(3003181) Sodium [Moles/volume] in Urine

384

1811

2.16

42.48

1.6

1.3

55.14

62.48

mmol/l

3.04

296

1447

(3023103) Potassium [Moles/volume] in Serum or Plasma

10014

94795

1.55

41.72

34.9

19.7

4.00

3.98

mmol/l

4.33

9912

92725

(3028626) Oxygen [Partial pressure] in Capillary blood

470

2415

1.99

41.28

3.7

3.1

8.14

8.02

kpa

0.93

462

2355

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

307

1337

2.33

41.19

6.9

6.3

12.15

11.95

mg/l

0.31

282

1234

(4062490) Immunoglobulin typing, IgG

224

846

2.68

40.70

1.6

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

505

2673

1.93

40.68

4.5

3.3

1.84

2.02

index

0.35

249

1396

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

388

1874

2.11

40.37

1.3

1.2

31.44

47.43

u/ml

1.38

177

(3039162) Centromere protein B Ab [Units/volume] in Serum

261

1071

2.47

39.98

1.3

62.78

52.26

u/ml

0.21

(3006184) Hemoglobin [Mass/volume] in Capillary blood

464

2404

1.97

39.80

2.5

2.3

126.02

129.05

g/l

1.68

356

1858

(3044889) 12 lead EKG panel

7444

67253

1.32

39.54

5.5

4.2

0.45

3580.31

0.91

146

(3027135) IgG subclass 1 [Mass/volume] in Serum

224

861

2.63

39.31

1.5

1.4

6.86

7.02

g/l

0.22

176

612

(3024139) IgG subclass 3 [Mass/volume] in Serum

224

862

2.63

39.22

1.5

1.4

0.42

0.46

g/l

0.55

173

614

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

890

5613

1.64

39.19

3.1

3.5

4.36

4.45

pmol/l

1.75

789

5023

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

468

2445

1.95

39.18

1.7

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

224

863

2.63

39.13

1.5

1.4

3.03

2.97

g/l

0.17

174

617

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

9349

87545

1.42

38.79

8.7

6.5

40.91

39.62

mmol/mol

30.91

8841

81363

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

583

3293

1.81

38.29

4.5

3.8

24.58

24.92

mmol/l

1.90

544

2969

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

171

579

2.98

38.12

1.2

75.44

84.12

0.59

(3013005) Retinol [Moles/volume] in Serum or Plasma

119

322

3.72

37.98

2.4

1.6

2.04

1.97

umol/l

0.41

111

297

(3002179) Metamyelocytes/Leukocytes in Blood

1249

8574

1.51

37.96

4.7

4.1

0.75

0.70

0.26

449

2567

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

531

2922

1.86

37.94

4.1

3.0

1.86

1.59

mg/l

8.22

490

2635

(3010370) Gastrin [Moles/volume] in Serum or Plasma

105

6.12

37.29

2.3

1.9

48.52

33.22

pmol/l

0.83

(40768441) Liver Pathology biopsy report

185

663

2.82

37.20

2.1

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

609

3521

1.77

36.96

3.3

3.0

0.31

0.36

iu/ml

3.33

324

1946

(3021901) Oxygen saturation in Capillary blood

413

2109

2.00

36.92

3.7

3.0

90.12

89.54

1.19

402

2047

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

471

2527

1.90

36.41

1.7

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

204

780

2.65

36.21

1.1

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

927

6026

1.59

35.92

2.5

2.4

20.33

22.59

au/ml

0.32

589

(21494890) Protein electrophoresis panel - 24 hour Urine

247

1039

2.41

35.88

1.8

2.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

360

1771

2.07

35.68

1.2

1.3

176.00

184.65

titre

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

359

1770

2.06

35.37

1.2

1.3

179.13

338.15

titre

0.70

154

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

237

986

2.43

35.28

1.2

58.36

66.97

u/l

0.96

205

847

(3041096) Erythrocytes [Presence] in Urine by Automated

3258

26625

1.32

35.20

4.8

3.4

0.54

0.25

estimate

0.43

1097

8504

(44790049) Parainfluenza type 3 nucleic acid detection

265

1165

2.31

34.83

1.7

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

265

1165

2.31

34.83

1.7

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

265

1165

2.31

34.83

1.7

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

265

1165

2.31

34.83

1.7

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

182

670

2.74

34.81

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

182

671

2.74

34.72

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

185

693

2.70

34.22

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

183

682

2.71

34.19

1.1

—

(3021440) Promyelocytes/Leukocytes in Blood

1236

8650

1.48

33.97

5.0

4.3

0.16

0.12

0.60

379

2374

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

175

645

2.74

33.42

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

853

5529

1.59

33.39

1.3

39.29

58.84

au/ml

1.72

375

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

177

657

2.72

33.34

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

349

1752

2.02

32.74

1.7

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

411

2184

1.92

32.71

1.6

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

140

464

3.04

32.46

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

140

464

3.04

32.46

1.4

—

(3025159) Blasts/Leukocytes in Blood

1235

8730

1.47

32.16

5.3

4.4

0.13

0.35

1.69

369

2257

(3018333) Ribosomal P Ab [Presence] in Serum

170

633

2.71

31.85

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

389

2056

1.92

31.47

1.7

1.6

—

(1616796) Gas panel - Central venous blood

418

2263

1.88

31.43

4.5

3.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

130

422

3.11

31.25

1.5

1.2

353.12

442.76

u/l

0.32

121

393

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

449

2505

1.83

30.68

2.1

2.0

12.56

12.02

mg/l

0.63

423

2346

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

261

1207

2.19

30.40

1.2

5.32

6.34

u/ml

—

(3000475) Leukocytes [#/volume] in Synovial fluid

441

2457

1.83

30.27

1.7

1.6

17826.95

15571.20

e6/l

0.29

316

1723

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

392

2105

1.89

30.23

3.0

3.6

220.03

1258.14

u/ml

2.45

356

1920

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

735

4708

1.60

30.18

5.4

4.7

1.70

1.59

2.14

708

4460

(3007930) Methemoglobin/Hemoglobin.total in Blood

676

4274

1.62

29.28

5.7

5.0

0.91

0.87

1.38

648

4033

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

150

555

2.73

28.50

1.3

1.2

33.82

25.57

u/l

0.51

127

450

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

234

1064

2.22

28.44

3.3

3.7

11.28

16.66

nmol/l

0.31

226

1038

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

152

568

2.70

28.33

1.3

1.2

120.33

90.33

u/l

1.49

129

474

(3037121) Protein [Mass/volume] in Urine

538

3243

1.69

28.07

3.4

3.2

687.82

515.71

mg/l

0.26

278

1446

(3010421) pH of Blood

538

3250

1.69

27.84

4.7

3.6

7.41

2.18

532

3201

(3047181) Lactate [Moles/volume] in Blood

496

2932

1.72

27.80

6.0

5.7

1.32

mmol/l

0.04

437

2597

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

113

363

3.13

27.70

2.0

1.9

100.78

122.48

umol/l

0.38

181

(3019225) pH of Specimen

1242

9025

1.42

27.66

5.2

4.2

7.36

0.35

949

6427

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

395

2195

1.83

27.36

1.6

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

460

2675

1.75

27.33

1.5

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

232

1078

2.18

26.75

1.3

—

nmol/l

—

(40757494) Bilirubin.total [Moles/volume] in Blood

133

480

2.79

26.53

2.5

2.2

16.02

32.91

umol/l

0.70

(3000330) Specific gravity of Urine by Test strip

757

5028

1.54

26.48

4.0

3.4

1.02

ratio

0.67

680

4573

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

211

948

2.25

26.43

1.3

1.61

1.48

nmol/l

0.80

194

850

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1399

10471

1.38

26.13

4.4

3.5

—

(40768446) Kidney Pathology biopsy report

102

320

3.21

26.04

1.9

1.6

—

(3006270) Folate [Moles/volume] in Blood

169

695

2.45

25.91

1.2

1.1

322.79

358.13

nmol/l

1.35

153

560

(3001186) Copper [Moles/volume] in Serum or Plasma

202

3.83

25.81

1.4

1.2

16.57

16.23

umol/l

0.24

181

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

342

1854

1.87

25.65

1.6

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

315

1669

1.91

25.35

1.7

1.6

—

(4024509) Urine culture

683

4499

1.55

24.78

2.1

1.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

181

786

2.32

24.60

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

811

5554

1.50

24.52

1.2

111.21

137.55

u/ml

1.18

298

2007

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

104

344

3.04

24.31

2.5

1.5

25.18

30.06

umol/l

4.87

323

(3044927) Protein electrophoresis panel - Urine

207

956

2.19

24.28

1.3

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

255

1276

2.02

24.23

1.3

0.63

3.24

nmol/l

0.92

248

1234

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

361

2027

1.81

24.19

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

361

2027

1.81

24.19

1.4

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

185

819

2.28

24.05

2.3

2.4

27.57

26.17

iu/ml

0.05

100

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

182

3.86

23.79

3.5

2.4

31.29

79.25

ug/l

0.50

182

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

9316

88617

1.31

23.72

26.9

16.4

76.77

78.10

ml/min/173m2

7.18

8906

82207

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

391

2263

1.75

23.64

2.5

2.4

131.30

110.32

ug/min

0.35

236

1332

(3006653) Thiamine [Moles/volume] in Blood

116

415

2.81

23.57

1.2

144.03

136.33

nmol/l

0.79

116

415

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

109

379

2.89

23.34

1.7

1.4

3161582.82

1047920.50

iu/ml

0.59

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

6.35

23.04

3.7

1.8

14.90

19.97

0.41

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

4.97

22.93

2.4

2.8

0.47

0.53

u/field

0.14

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

9353

89165

1.30

22.34

6.4

5.3

6.18

5.99

mmol/l

31.69

8764

81356

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

255

1318

1.96

22.13

1.3

0.14

0.20

nmol/l

1.99

104

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

155

660

2.37

22.08

1.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

230

3.41

22.05

3.4

3.5

7.06

8.18

mg/l

0.83

192

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

291

3.11

21.92

1.3

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

209

1010

2.09

21.87

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

252

1304

1.95

21.80

2.4

1.08

1.23

g/24h

0.53

156

764

(3005988) Vibrio sp identified in Specimen by Organism specific culture

209

1012

2.09

21.75

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

214

1047

2.06

21.67

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

217

1068

2.05

21.62

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

207

1005

2.08

21.40

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

213

1049

2.05

21.20

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

222

1112

2.02

21.09

2.8

2.0

20.93

26.22

mg/l

1.07

418

(3043410) Blood group antigens tested for on Red Blood Cells

227

3.36

21.08

2.2

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

212

1045

2.05

21.05

1.4

—

(3012501) Base excess in Blood by calculation

360

2105

1.73

21.03

5.1

3.9

2.79

2.50

mmol/l

1.05

260

1422

(3013290) Carbon dioxide [Partial pressure] in Blood

360

2106

1.73

20.99

5.1

3.9

5.04

4.98

kpa

0.73

352

2052

(3027456) Digoxin [Moles/volume] in Serum or Plasma

382

2272

1.71

20.98

3.5

3.2

0.82

nmol/l

0.01

301

1826

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1479

11524

1.33

20.94

12.3

6.9

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

219

3.39

20.82

2.5

1.8

8.67

9.25

mg/l

0.38

181

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

249

3.23

20.77

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

201

3.50

20.64

2.7

184.14

121.96

au/ml

0.46

(3028707) Methadone [Presence] in Urine by Screen method

196

946

2.09

20.60

3.5

2.6

—

(3027315) Oxygen [Partial pressure] in Blood

360

2118

1.72

20.58

5.1

4.0

8.49

8.58

kpa

0.41

352

2063

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

5.27

20.55

3.9

1.9

58.52

63.35

0.29

(4035726) Immunohistochemistry procedure

1172

8852

1.36

20.41

1.5

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

193

933

2.09

20.21

1.1

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

9016

85832

1.26

19.91

5.1

4.3

1.38

1.29

mmol/l

23.17

8408

78193

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

120

477

2.53

19.89

2.1

1.9

2.15

3.18

u/field

0.69

324

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

324

1869

1.76

19.87

1.6

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

6.42

19.61

2.7

2.6

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

7.73

19.52

1.5

1.7

165.43

174.57

ug/g

0.09

(1761868) Lipid panel - Serum or Plasma

2952

34198

0.81

19.37

3.5

3.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

8.35

19.24

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

4.95

19.18

1.3

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

239

1270

1.90

19.16

1.8

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

314

1823

1.74

18.85

2.5

1.6

0.81

0.86

nmol/l

0.64

265

1552

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

7.66

18.66

1.1

17.52

35.49

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

7.66

18.66

1.1

45.20

20.44

u/ml

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

147

659

2.25

18.65

1.8

1.4

1.13

1.14

promille

0.02

116

515

(3010144) Erythrocytes [#/volume] in Synovial fluid

183

898

2.06

18.45

1.3

1.4

163404.34

126295.32

e6/l

0.22

116

604

(3051611) Lipemic interference index of Serum or Plasma

195

980

2.01

18.41

4.6

3.3

13.33

13.31

index

0.01

105

545

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

217

3.24

18.35

1.3

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

10095

97726

1.35

18.24

37.1

21.6

85.37

79.34

umol/l

27.89

10022

96476

(3023511) Choriogonadotropin [Units/volume] in Urine

178

869

2.07

18.20

1.6

1.3

—

(3023419) Bacteria identified in Sputum by Culture

230

1228

1.89

18.20

2.7

2.4

—

(3004451) EKG impression Narrative

130

562

2.33

17.98

1.4

1.3

—

(4211845) Urine protein measurement

110

441

2.51

17.96

4.1

3.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

233

1255

1.87

17.95

1.8

1.4

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

8052

75980

1.21

17.90

35.1

20.2

14.10

13.69

103.90

7997

74918

(3039000) Anion gap in Blood by calculation

342

2062

1.68

17.90

6.8

6.6

11.32

11.27

mmol/l

0.10

317

1846

(3018572) Chloride [Moles/volume] in Blood

342

2063

1.68

17.87

6.8

6.6

104.12

105.12

mmol/l

2.70

317

1848

(3006462) Nitrate [Presence] in Urine

103

402

2.58

17.78

4.2

3.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

365

2244

1.65

17.73

1.2

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9995

96671

1.33

17.73

19.3

12.0

26.29

25.97

u/l

1.01

9820

93483

(21494755) Public health laboratory ask at order entry panel

460

6888

0.65

17.42

1.3

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

188

952

1.99

17.40

3.7

3.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

225

1211

1.88

17.38

1.2

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

349

2136

1.65

17.26

3.5

2.6

15.77

16.33

2.67

344

2091

(3016038) Potassium [Moles/volume] in Urine

144

664

2.18

17.10

1.4

1.1

29.94

35.30

mmol/l

2.16

131

561

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

599

8490

0.69

17.09

1.9

2.0

3.63

3.47

ratio

2.05

462

6636

(3022493) Free Hemoglobin [Mass/volume] in Plasma

102

405

2.53

17.01

4.7

5.2

57.16

1185.65

mg/l

0.83

285

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

806

5905

1.39

16.85

2.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

211

1124

1.89

16.84

1.2

1.3

0.18

0.21

nmol/l

1.11

167

895

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

176

889

2.00

16.44

3.4

2.8

—

(3011412) CD3 cells [#/volume] in Blood

164

812

2.03

16.20

2.2

2.4

1145.55

1130.41

e6/l

0.08

150

727

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

105

433

2.44

16.19

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

126

563

2.25

16.18

1.7

1.3

—

(21494434) Karyotype in Bone marrow

173

874

1.99

16.16

1.3

1.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

262

2.88

16.07

1.0

1.1

—

(3008295) Osmolality of Serum or Plasma

196

1040

1.90

15.86

1.5

1.3

276.16

278.00

mosm/kgh2o

0.51

163

773

(4198724) Urine methamphetamine measurement

248

2.92

15.83

4.8

2.0

—

(40768443) Skin Pathology biopsy report

627

4444

1.44

15.82

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

865

6477

1.36

15.80

2.1

2.0

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

175

895

1.97

15.79

1.2

17.11

36.21

u/ml

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

541

3735

1.47

15.68

2.1

2.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

160

796

2.02

15.61

2.1

2.0

14.19

1.69

u/field

0.50

103

421

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

180

934

1.94

15.58

1.4

1.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

208

1135

1.85

15.45

37.1

5.9

7.71

7.35

mmol/l

0.68

174

949

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

154

3.45

15.44

1.8

1.5

67.75

137.04

au/ml

—

(3042631) Mycobacterium sp identified in Specimen

236

1341

1.78

15.34

2.6

2.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

190

1013

1.89

15.18

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

205

1120

1.85

15.17

1.5

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

260

2.82

15.12

1.1

1.3

153.68

121.51

nmol/l

0.53

184

(44813793) Dust mix specific IgE antibody measurement

123

562

2.20

15.00

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

259

1523

1.72

14.94

1.6

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

304

1866

1.65

14.92

2.3

2.2

8513.67

5132.82

u/l

0.62

743

(3045683) HLA typing for celiac disease panel - Blood or Tissue

401

2.43

14.91

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

238

1369

1.75

14.85

1.6

1.4

2222.68

3041.90

e6/l

0.42

157

948

(3028308) Erythrocytes [#/volume] in Pleural fluid

218

1226

1.79

14.69

1.6

1.4

75825.96

59007.15

e6/l

0.41

119

685

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

500

3447

1.47

14.62

2.0

1.8

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

107

467

2.30

14.57

2.0

1.4

14.13

23.35

umol/l

5.04

100

429

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1074

8403

1.31

14.50

5.4

3.8

1.22

1.23

mmol/l

3.68

980

7147

(3000012) Reticulocyte production index

266

1595

1.68

14.30

2.3

2.1

0.88

0.91

0.29

197

1051

(3003434) Protein [Mass/volume] in Pleural fluid

263

1573

1.69

14.27

1.6

1.4

149.94

32.68

g/l

0.49

230

1417

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

419

6140

0.67

14.22

1.6

1.7

3.56

3.46

mmol/l

0.89

279

4272

(3016750) Collection duration of Urine

117

536

2.20

14.20

2.5

2.3

501.76

498.58

min

0.15

101

383

(3010838) Calcium [Moles/time] in 24 hour Urine

274

1659

1.67

14.20

2.1

1.8

4.56

4.97

mmol/24h

1.35

247

1475

(3006571) Granulocytes/Leukocytes in Synovial fluid

208

1166

1.80

14.19

1.4

1.6

57.55

59.73

0.31

132

715

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

114

517

2.22

14.19

1.6

1.5

7.81

5.89

u/l

0.68

451

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

136

662

2.07

14.13

3.1

1.7

—

(3003129) Base excess in Capillary blood by calculation

201

1118

1.81

14.07

2.3

0.88

0.43

mmol/l

0.86

188

1070

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

5.82

13.97

1.4

1.3

40.29

44.65

mg/l

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

166

871

1.92

13.96

1.4

1.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

131

632

2.09

13.94

2.2

2.1

15.83

16.00

0.05

126

611

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

7950

75513

1.18

13.89

38.6

21.1

330.79

332.05

g/l

26.86

7908

75057

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

132

640

2.08

13.87

2.3

2.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

114

522

2.20

13.87

2.9

2.7

37.08

37.26

0.03

287

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

330

2106

1.58

13.84

1.2

1.1

3.05

3.96

0.92

251

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

119

558

2.14

13.65

1.3

0.87

1.50

u/ml

0.79

331

(3008898) HLA-B27 [Presence]

388

2579

1.52

13.57

1.1

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

4.77

13.51

1.5

1.2

1.02

1.05

ml/s/173m2

0.03

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

179

3.08

13.40

1.3

1.2

—

(3049717) Cytology report of Urine Cyto stain

560

4016

1.42

13.26

2.6

2.8

—

(3006245) CD3-CD19+ cells/cells in Blood

291

2.59

13.22

2.3

2.4

11.22

9.74

0.29

263

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

321

2058

1.58

13.22

1.3

4.02

3.81

mmol/l

1.18

302

1964

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

147

756

1.96

13.14

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

147

756

1.96

13.14

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

147

756

1.96

13.14

1.4

1.6

—

(1175426) CD3 cells/Lymphocytes in Blood

134

667

2.02

13.14

2.2

2.1

70.60

71.75

0.28

129

631

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

112

524

2.15

12.94

2.0

2.6

449.62

514.65

e6/l

1.03

424

(21491868) Cryoglobulin [Mass/volume] in Serum

342

2.44

12.91

1.2

1.07

0.22

g/l

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9527

92187

1.23

12.79

7.0

5.9

2.52

2.66

mmol/l

44.92

8987

85223

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

145

751

1.94

12.71

2.0

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

368

2456

1.52

12.66

1.9

24.92

6.50

iu/l

0.41

146

961

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

9315

89953

1.22

12.63

6.0

5.1

1.40

1.46

mmol/l

39.63

8761

82896

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

134

2526

0.52

12.60

1.1

0.69

0.62

ratio

0.44

384

(3017704) Immunofixation for Urine

114

545

2.10

12.48

1.4

1.5

—

(3045424) Erythrocytes [Presence] in Urine

641

4757

1.37

12.39

2.5

2.1

0.00

0.21

estimate

0.65

178

1501

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

212

1248

1.71

12.27

1.3

1.2

3.61

4.03

u/ml

0.24

112

576

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

285

2.54

12.22

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

239

1458

1.65

12.10

1.8

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

367

2472

1.50

12.10

1.1

—

(3004809) Band form neutrophils/Leukocytes in Blood

265

1660

1.61

12.07

3.1

3.5

1.48

1.68

0.44

236

1466

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

348

2328

1.51

11.86

1.3

596.43

577.65

mg/l

0.08

338

2237

(3035947) Staphylolysin Ab [Units/volume] in Serum

445

2.19

11.82

1.2

1.1

3.71

4.13

iu/ml

—

(3008037) Lactate [Moles/volume] in Venous blood

375

2551

1.49

11.78

4.3

3.1

1.56

1.61

mmol/l

0.64

369

2477

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9360

90558

1.21

11.74

6.1

5.2

4.40

4.59

mmol/l

53.71

8859

83987

(3029634) Reagin Ab [Titer] in Serum by VDRL

186

1072

1.75

11.63

2.3

3.14

3.58

titre

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

313

2056

1.54

11.62

1.5

1.4

659.29

1437.75

e6/l

1.76

259

1626

(40768806) Pleura Pathology biopsy report

199

1172

1.71

11.52

1.6

1.5

—

(3004775) Volume in Urine collected for unspecified duration

141

750

1.89

11.47

2.7

2.3

732.57

656.72

1.63

116

488

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

230

2.66

11.44

1.9

1.6

11.11

9.14

ug/l

1.70

230

(3008757) Leukocyte morphology finding [Identifier] in Blood

173

982

1.77

11.41

3.1

3.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

308

2025

1.54

11.40

1.4

7.12

28.26

e6/l

3.77

242

1501

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

133

696

1.92

11.36

1.4

1.3

763.85

295.29

titre

0.61

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

110

540

2.05

11.27

2.1

2.7

211.54

240.15

e6/l

0.82

468

(3000060) B lymphocytes [#/volume] in Blood

198

2.79

11.27

2.3

2.5

3.85

0.25

e9/l

0.69

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

129

673

1.93

11.13

1.4

1.3

27.50

77.74

titre

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

112

557

2.02

11.09

1.7

1.5

8.07

6.58

u/l

0.38

438

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

181

1053

1.73

10.98

1.5

1.3

307.39

390.48

u/l

1.38

158

1013

(3034274) Bile acid [Moles/volume] in Serum --fasting

132

698

1.90

10.95

1.7

2.0

12.37

7.72

umol/l

0.61

506

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

486

3521

1.40

10.90

1.9

2.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

244

1542

1.60

10.76

1.2

0.45

0.87

—

(3047189) Immunofixation for 24 hour Urine

102

497

2.06

10.69

1.5

1.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.34

10.49

1.0

1.1

0.10

0.03

u/ml

0.56

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

141

3.06

10.43

2.6

3.0

38.94

65.77

mg/l

0.72

(3002256) Pathology report gross observation

1567

13280

1.21

10.39

1.4

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

124

655

1.90

10.35

1.5

1.4

14.93

13.26

umol/l

1.33

116

612

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

153

864

1.78

10.32

1.6

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

209

1292

1.63

10.12

4.9

5.0

321.94

358.36

umol/l

3.37

191

1115

(3044290) Cell count panel - Cerebral spinal fluid

284

1885

1.52

10.11

1.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

136

746

1.83

10.10

1.3

1.2

15.50

76.13

u/ml

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

177

1049

1.70

10.08

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

133

726

1.84

10.04

1.5

1.2

105.33

109.18

pmol/l

0.31

133

726

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1350

11312

1.22

10.03

5.2

5.0

32.91

32.60

0.46

955

7314

(3038515) Glucose [Moles/volume] in Venous blood

311

2117

1.48

9.81

4.6

3.2

7.74

7.67

mmol/l

0.12

305

2059

(40762887) Creatinine [Moles/volume] in Blood

4.52

9.75

1.7

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

207

1289

1.62

9.75

1.3

1.2

3.05

3.75

u/ml

0.34

467

(3020491) Glucose [Moles/volume] in Blood

115

605

1.91

9.74

1.9

6.89

6.90

mmol/l

0.01

417

(3017354) Segmented neutrophils/Leukocytes in Blood

177

1061

1.68

9.68

3.1

3.4

58.54

57.89

0.15

147

895

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

370

2.17

9.64

2.2

1.9

169.57

164.62

0.16

350

(3009871) Measles virus Ab [Titer] in Serum

295

2.31

9.55

1.5

1.7

4525.71

2872.73

titre

—

(40761536) Microorganisms panel - Urine sediment

957

7772

1.25

9.51

5.6

4.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

176

1059

1.67

9.50

1.4

1.3

6.47

6.30

mmol/l

0.32

161

973

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

145

831

1.75

9.34

1.8

5.29

4.10

mg/l

1.46

138

791

(3042517) Benzodiazepines panel - Urine

4.67

9.28

2.7

2.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.63

9.24

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

100

512

1.96

9.20

1.4

1.20

1.24

nmol/l

0.12

386

(4281824) Cell count and differential, peritoneal fluid

178

1084

1.65

9.19

1.3

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

269

2.35

9.19

1.2

0.32

0.31

g/l

0.23

214

(3003329) Lymphocytes/Leukocytes in Synovial fluid

154

903

1.72

9.16

1.4

1.5

25.18

30.26

1.14

101

546

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

116

626

1.86

9.12

1.3

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.01

9.08

1.5

1.7

1.31

1.73

mg/l

0.17

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.01

9.08

1.5

1.7

1.68

1.81

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.01

9.08

1.5

1.7

1.28

2.67

mg/l

0.71

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.01

9.08

1.5

1.7

0.74

0.99

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.01

9.08

1.5

1.7

4.92

3.35

mg/l

0.34

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

5.01

9.08

1.5

1.7

0.84

2.11

mg/l

0.83

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.01

9.08

1.5

1.7

2.35

2.87

mg/l

0.16

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.01

9.08

1.5

1.7

2.75

1.05

mg/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

217

2.50

8.99

2.0

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

143

2.87

8.98

2.3

2.0

19.47

17.54

umol/l

0.43

143

(40757373) Influenza virus identified in Isolate

155

2.78

8.87

2.0

1.5

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.88

8.82

1.5

1.7

1.85

1.28

mg/l

0.17

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.88

8.82

1.8

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

594

4589

1.31

8.81

2.8

4.0

51.13

77.59

u/ml

1.40

572

4434

(1001926) Buprenorphine [Presence] in Urine by Screen method

265

1788

1.49

8.78

3.6

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

399

2905

1.39

8.76

1.8

2.0

—

(4268621) Lupus anticoagulant assay

152

900

1.70

8.75

2.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

139

803

1.74

8.74

1.7

1.5

20.96

24.77

u/ml

0.55

159

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

446

2.00

8.73

3.5

3.4

1.39

1.30

0.18

446

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.27

8.73

2.5

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

113

614

1.85

8.72

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

301

2.23

8.71

1.1

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

149

879

1.70

8.70

1.1

2.76

1.81

iu/ml

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.66

8.70

1.9

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

245

2.37

8.69

1.9

20.40

34.84

u/l

0.71

227

(3011985) Renin [Units/volume] in Plasma

218

1414

1.55

8.69

1.6

1.4

85.08

63.80

mu/l

0.48

192

1260

(3007461) Platelets [#/volume] in Blood

10133

99262

1.23

8.67

44.2

24.7

246.69

247.21

e9/l

0.30

10036

96905

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

179

1109

1.62

8.66

1.2

1.1

2.43

2.95

0.27

156

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

223

1455

1.54

8.66

1.2

1.1

1.10

1.80

u/ml

1.42

134

752

(3045142) Bone marrow Pathology biopsy report

184

1148

1.61

8.65

1.4

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

134

770

1.75

8.60

1.8

1.4

15.50

12.93

u/l

3.14

129

741

(3024731) MCV [Entitic mean volume] in Red Blood Cells

10134

99284

1.23

8.58

43.9

24.6

91.50

91.44

0.51

10066

98041

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

210

1355

1.56

8.57

1.1

12.65

8656.73

iu/ml

0.55

276

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

10134

99288

1.23

8.56

45.1

25.1

39.17

40.61

23.64

10063

97994

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

205

1316

1.57

8.56

1.1

32.89

16.74

au/ml

1.10

288

(3010813) Leukocytes [#/volume] in Blood

10136

99311

1.23

8.55

44.1

24.7

7.03

6.78

e9/l

16.87

10021

96572

(3035941) MCH [Entitic mass]

10133

99283

1.22

8.51

43.9

24.6

30.31

30.41

6.57

10066

98040

(3021387) Prolactin [Units/volume] in Serum or Plasma

326

2304

1.43

8.51

1.8

1.7

352.71

297.11

mu/l

1.60

298

2112

(3026361) Erythrocytes [#/volume] in Blood

10133

99291

1.22

8.46

44.1

24.6

4.36

4.47

e12/l

76.42

10020

96558

(3000963) Hemoglobin [Mass/volume] in Blood

10134

99309

1.22

8.41

44.5

24.8

130.67

134.90

g/l

130.79

10068

98092

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

369

2671

1.39

8.40

1.9

1.8

—

31.36

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

4.64

8.33

1.8

1.4

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

107

3.09

8.22

1.1

1.5

8.49

298883.64

nmol/l

0.72

(3033923) Metanephrine [Moles/time] in 24 hour Urine

168

2.63

8.16

1.0

1.1

0.75

0.63

umol/24h

0.59

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

299

2101

1.43

8.07

1.4

1.3

233.87

220.38

miu/ml

0.21

108

900

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

162

1000

1.63

7.99

1.2

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

138

823

1.69

7.79

1.4

1.3

11.26

15.19

u/l

1.27

122

763

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

192

1243

1.55

7.77

2.1

1.8

—

(3011288) Drugs identified in Urine by Screen method Nominal

232

1565

1.49

7.75

5.3

2.6

—

(3016879) Cocaine [Presence] in Urine

302

2145

1.42

7.71

3.3

1.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4260

39625

1.12

7.65

2.1

1.9

1.42

1.34

mmol/l

7.21

3613

32835

(4212803) Bone marrow aspirate examination

3.26

7.63

1.2

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

241

2.29

7.63

1.1

1.3

92.63

84.62

0.82

130

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

258

1786

1.46

7.57

1.5

1.3

45.07

34.17

u/l

0.67

234

1525

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

127

747

1.71

7.56

1.3

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

263

2.21

7.43

1.2

10.89

11.92

pmol/l

0.14

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

245

2.25

7.36

1.1

1.2

92.84

86.50

0.85

127

(3000764) Benzodiazepines [Presence] in Urine

319

2311

1.39

7.29

3.2

1.9

—

(3028300) Cannabinoids [Presence] in Urine

321

2329

1.39

7.27

3.3

1.9

—

(3027008) Opiates [Presence] in Urine

320

2324

1.39

7.21

2.5

1.9

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

326

2.06

7.20

1.7

1458.43

41693.71

u/ml

—

(3038026) Centromere Ab [Units/volume] in Serum

113

653

1.74

7.19

1.3

1.2

7.86

63.31

u/ml

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

300

2.11

7.16

1.4

15.44

15.70

pmol/l

0.11

250

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

523

1.82

7.12

1.2

1.1

104.56

84.30

u/l

0.71

462

(4195642) Thrombophilia screening test

179

1165

1.55

7.11

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

302

2.09

7.05

5.8

2.0

—

(3027944) Amphetamines [Presence] in Urine

315

2291

1.39

7.04

3.3

1.9

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

257

2.18

6.99

1.2

111.26

111.11

0.02

224

(3003694) ABO and Rh group [Type] in Blood

2902

26539

1.13

6.78

1.5

1.4

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

488

1.83

6.78

2.6

204.53

205.40

u/l

0.04

480

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

518

1.80

6.73

1.2

1.1

34.10

26.81

u/l

0.39

455

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

173

2.43

6.73

1.2

714.50

293.21

pmol/l

0.46

126

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

469

1.84

6.67

2.1

2.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

325

2402

1.36

6.61

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

393

1.91

6.58

2.7

3.2

25.47

25.28

mu/l

0.02

371

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.15

6.54

1.1

1.12

1.74

iu/ml

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

523

1.78

6.53

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

176

2.39

6.50

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

102

2.85

6.34

1.3

1.2

0.10

0.49

u/ml

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

521

1.77

6.33

1.2

1.1

—

(4133840) Spirometry

223

2.20

6.29

1.1

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

126

2.62

6.20

1.2

1.4

47.53

42.86

mg/l

0.20

110

(3033099) Centromere Ab [Titer] in Serum

174

2.36

6.19

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

143

916

1.57

6.16

1.6

1.5

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

4.11

6.08

1.0

0.03

2.95

u/ml

0.58

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

566

1.72

6.03

1.1

11.07

10.08

iu/ml

0.08

143

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

434

1.83

6.03

1.1

1486.11

1514.70

miu/ml

0.09

434

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1127

9723

1.18

6.02

1.6

—

6.02

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

131

827

1.59

6.01

1.7

1.4

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

158

2.41

6.01

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

177

2.32

5.97

1.4

1.2

0.63

108.76

mg/l

1.30

127

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

117

2.65

5.97

1.4

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

193

1328

1.46

5.95

1.2

1.3

428.45

376.24

pmol/l

0.12

154

1112

(3026051) Granulocytes/Leukocytes in Pleural fluid

222

2.17

5.94

1.5

1.4

25.53

21.45

0.46

191

(3002079) Sodium [Moles/time] in 24 hour Urine

386

1.87

5.94

1.3

137.83

170.25

mmol/24h

2.21

386

(3035880) pH of Pleural fluid

554

1.72

5.93

1.3

7.39

7.40

0.21

379

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

143

925

1.55

5.92

2.0

1.9

1546.67

1516.19

titre

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

453

1.79

5.84

1.2

1.1

1.08

1.06

ratio

0.86

363

(3028679) Herpes simplex virus Ab [Presence] in Serum

432

1.81

5.81

1.2

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

305

1.97

5.80

1.1

13.93

5.72

u/ml

0.46

(3003888) Timothy IgE Ab [Units/volume] in Serum

183

1253

1.47

5.79

1.2

1.1

2.51

4.40

u/ml

1.87

623

(37021550) Renin [Units/volume] in Plasma --upright

161

2.36

5.78

1.3

80.42

67.55

mu/l

0.15

118

(43055442) Apixaban [Mass/volume] in Serum or Plasma

193

2.23

5.73

1.7

1.5

108.05

116.80

ug/l

0.25

162

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

3.70

5.63

10.4

9.1

330.09

370.56

e6/l

0.06

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

4.73

5.59

3.1

3.3

2.14

2.85

mg/l

0.72

(3012565) Volume of 24 hour Urine

482

1.75

5.58

2.3

2.1

1908.23

1916.46

0.01

414

(3017569) Oxygen content in Arterial blood

101

610

1.66

5.57

2.3

2.2

15.81

15.90

0.09

101

610

(3010503) CD19 cells [#/volume] in Blood

542

1.70

5.56

2.2

2.5

376.48

573.76

e6/l

0.25

520

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.36

5.52

2.5

3.8

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

2.73

5.51

1.2

1.0

96.88

74.11

ug/l

0.82

(3036071) Salmonella sp Ab [Titer] in Serum

273

1.98

5.33

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

700

5857

1.21

5.30

1.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

114

720

1.59

5.28

1.2

1.3

2.03

2.17

mmol/l

0.56

104

677

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1369

12114

1.15

5.24

1.5

—

(4015189) Microbial culture of sputum

221

2.09

5.22

2.3

2.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

163

2.27

5.19

1.2

0.83

1.48

mmol/l

0.51

113

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

509

1.69

5.15

3.9

3.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

100

616

1.63

5.14

1.3

1.2

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

284

1.94

5.13

1.4

1.3

61.02

57.02

0.36

240

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

172

1195

1.45

5.10

1.2

1.1

119.50

116.46

0.55

157

1076

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

113

722

1.57

5.01

1.6

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

108

1666

0.64

4.95

1.7

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

213

2.07

4.91

1.2

1.1

1042.86

925.58

titre

0.27

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

3.48

4.88

1.0

0.02

0.19

u/ml

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

173

1218

1.43

4.80

1.2

1.1

0.83

0.92

u/ml

0.12

506

(3023410) Appearance of Cerebral spinal fluid

130

866

1.51

4.79

1.6

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

386

1.77

4.75

1.7

2.0

39.49

40.09

g/l

0.43

386

(3037692) Legionella sp identified in Specimen by Organism specific culture

321

1.84

4.73

1.9

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

190

2.11

4.71

1.1

—

(3014271) Vancomycin [Susceptibility]

508

1.66

4.68

3.6

2.9

—

(3025549) Creatine [Moles/time] in 24 hour Urine

3.02

4.66

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

419

1.72

4.62

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

419

1.72

4.62

1.3

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

174

1236

1.41

4.62

1.1

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

109

2.48

4.61

1.2

1.3

68.39

75.03

0.38

(3009214) Lutropin [Units/volume] in Serum or Plasma

280

2145

1.31

4.60

1.3

1.4

11.65

10.35

u/l

0.85

214

1739

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

5.46

4.59

1.1

2.0

395.86

248.47

nmol/l

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

282

1.88

4.56

1.2

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

234

1.97

4.52

1.4

1.2

40.26

37.68

0.14

152

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.27

4.46

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.58

4.46

2.4

1.9

0.32

0.94

mmol/l

1.52

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

193

1405

1.38

4.45

1.6

1.9

16.87

25.68

ug/l

4.97

187

1370

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.09

4.35

1.2

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

315

2471

1.28

4.35

5.1

4.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

360

1.75

4.33

1.1

3.33

21.59

u/ml

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3661

34517

1.09

4.33

5.6

5.7

2.84

3.58

ug/l

0.93

3342

31101

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

458

1.66

4.32

2.0

2.1

97.17

170.17

ug/min

0.57

109

(4146454) Self-monitoring of blood glucose

145

1010

1.44

4.31

3.0

2.6

—

(3023383) Lactate [Moles/volume] in Pleural fluid

324

1.79

4.31

1.5

1.3

3.04

3.46

mmol/l

0.58

299

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

134

920

1.46

4.30

1.2

1.1

98.13

96.84

0.20

128

868

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

178

2.08

4.25

1.2

1.3

82.56

77.22

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.70

4.24

1.1

252.17

341.93

u/ml

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

108

712

1.52

4.23

1.2

1.3

11.34

8.82

mmol/l

5.27

100

672

(3044242) Glucose [Moles/volume] in Arterial blood

612

1.56

4.14

2.3

2.0

8.57

7.93

mmol/l

0.81

612

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.34

4.12

1.1

1.2

0.23

0.90

iu/ml

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

141

2.20

4.10

1.2

29.36

88.21

u/l

0.81

104

(3013762) Body weight Measured

4.62

4.05

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

203

1.97

4.00

1.2

1.81

1.58

mmol/l

0.41

129

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

111

2.35

3.98

2.0

1.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

5.56

3.97

1.0

0.04

u/ml

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

312

1.77

3.92

2.3

1.9

1.64

1.70

ratio

0.10

300

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

487

1.61

3.90

1.3

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.45

3.87

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

434

1.64

3.86

1.4

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

434

1.64

3.86

1.4

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

434

1.64

3.86

1.4

1.9

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

119

2.27

3.86

2.6

3.8

42.29

39.91

umol/l

0.24

105

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

435

1.64

3.83

1.4

1.8

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

561

1.56

3.81

1.1

0.68

8.40

nmol/l

1.74

108

(3023323) Follitropin [Units/volume] in Serum or Plasma

384

3137

1.23

3.79

1.4

30.52

30.46

iu/l

0.01

328

2682

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.53

3.79

1.0

1.1

1.43

0.26

u/ml

0.47

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

3.94

3.78

1.1

1.0

0.03

3.51

u/ml

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

8.75

3.77

2.4

1.1

2.31

2.29

g/l

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

180

2.00

3.77

1.1

1.3

65.00

73.48

—

(3024263) Appearance of Synovial fluid

476

1.60

3.76

1.3

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

118

815

1.45

3.73

1.1

—

(3034426) Prothrombin time (PT)

266

1.81

3.71

1.2

28.15

28.73

0.34

266

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

164

1202

1.37

3.70

1.1

—

(4034850) Laboratory test

359

2922

1.24

3.68

12.8

10.6

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

109

2.30

3.67

1.2

1.0

1.62

3.28

u/ml

0.27

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

109

744

1.47

3.67

2.1

1.7

364.88

359.08

mu/l

0.06

599

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

418

1.63

3.64

1.6

7.39

5.19

nmol/l

0.26

339

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

270

2131

1.27

3.62

2.1

1.9

189.49

203.52

pmol/l

1.78

258

2003

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.86

3.62

1.1

1.0

0.01

9.75

u/ml

—

(3048879) Bone marrow aspiration report

254

1.81

3.61

1.5

1.7

—

2.00

—

(3025130) Human papilloma virus identified in Specimen

154

1123

1.38

3.60

1.9

1.8

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.00

3.59

1.1

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

171

1.99

3.52

2.8

5.9

90.47

50.27

u/l

0.55

166

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

316

1.71

3.49

1.5

1.3

25.87

434.67

ug/l

2.32

165

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

317

1.71

3.46

3.2

2.9

5.03

4.99

kpa

0.09

317

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

258

1.79

3.44

1.2

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

488

1.56

3.43

1.3

1.5

1.95

2.99

0.89

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

318

1.70

3.42

3.2

2.9

10.11

10.12

kpa

0.01

318

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.55

3.42

1.0

1.2

28.24

35.00

umol/24h

—

(3028433) Virus identified in Specimen by Culture

281

1.75

3.41

1.2

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.98

3.40

2.9

3.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.08

3.39

7.5

6.0

456.82

397.96

umol/l

0.48

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.66

3.39

1.1

0.39

0.86

u/ml

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

327

1.69

3.37

1.2

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

327

1.69

3.37

1.2

2.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

509

1.54

3.29

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

155

2.00

3.28

1.1

1.0

0.48

7.27

u/ml

0.61

(3024869) Neuronal Ab [Presence] in Serum

190

1.90

3.27

1.0

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

377

1.62

3.24

2.2

1.9

32.03

31.35

0.11

377

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.38

3.22

1.0

1.2

2.07

1.69

umol/24h

0.51

(3020393) Adenovirus Ag [Presence] in Stool

2.38

3.22

1.2

1.3

—

(3016031) Almond IgE Ab [Units/volume] in Serum

3.34

3.21

1.1

1.0

0.14

u/ml

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

332

1.66

3.21

1.3

2.1

—

(3016135) IgD [Mass/volume] in Serum

6.37

3.18

1.4

1.3

21.93

179.71

mg/l

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.25

3.12

1.0

—

(44806071) Cardiolipin IgM antibody measurement

2.25

3.12

1.1

—

(40768800) Prostate Pathology biopsy report

186

2397

0.77

3.08

1.1

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

109

772

1.42

3.08

4.0

5.8

77.46

84.00

u/ml

0.05

259

(3018291) Platelet Ab [Presence] in Serum

5.00

3.05

1.4

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

105

742

1.42

3.01

3.2

2.6

28.82

31.49

mg/l

0.27

528

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

129

947

1.37

2.97

1.4

30.94

29.65

u/l

0.16

104

787

(3016228) CD19 cells/cells in Blood

372

1.59

2.93

2.2

1.9

7.92

8.68

0.18

360

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

128

2.03

2.90

1.9

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.21

2.89

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

583

1.46

2.87

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.59

2.87

1.1

1.0

0.03

0.45

u/ml

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

5.39

2.86

1.4

1.0

237.71

232.85

u/ml

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.25

2.86

1.3

1.0

0.10

5.18

u/ml

0.72

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

232

1861

1.25

2.80

1.4

1.5

211.44

188.30

pmol/l

0.12

227

1803

(3003740) Influenza virus B Ag [Presence] in Specimen

169

1304

1.30

2.79

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.54

2.78

1.3

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.31

2.74

1.3

1.2

5.97

6.13

mmol/l

0.25

(3002523) Influenza virus A Ag [Presence] in Specimen

168

1302

1.29

2.70

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

381

1.55

2.67

1.2

1.1

305.25

186.93

iu/ml

0.85

376

(3004347) Hepatitis D virus Ab [Presence] in Serum

4.21

2.67

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.33

2.64

1.9

2.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

289

1.63

2.61

1.5

1.4

664.54

261.01

nmol/24h

0.30

289

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

113

2.04

2.60

1.1

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

466

1.48

2.56

1.6

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

299

1.61

2.55

1.2

37.85

39.67

g/l

0.44

158

(3046682) IgA [Presence] in Skin by Immunofluorescence

5.46

2.54

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

2.13

2.54

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

459

1.48

2.53

1.2

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.50

2.52

1.1

1.0

0.13

1.41

u/ml

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

326

2742

1.19

2.52

1.9

1.8

41.72

42.86

nmol/l

0.42

319

2665

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.97

2.48

1.1

1.0

0.05

0.11

u/ml

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.38

2.47

1.3

—

(3007463) Buprenorphine [Presence] in Urine

4.38

2.47

16.7

8.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

150

1161

1.30

2.47

1.1

1.40

1.30

u/ml

0.10

552

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

672

1.39

2.42

1.9

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

258

1.63

2.37

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

220

1.68

2.36

1.7

1.6

0.35

0.40

ug/l

0.37

152

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

168

1.79

2.35

1.5

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

651

1.39

2.34

1.2

49.05

44.60

mg/l

0.16

552

(3013727) Leukocytes other/Leukocytes in Blood

306

1.57

2.34

2.6

3.7

55.65

54.87

0.09

295

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

322

1.56

2.34

1.0

97.43

94.94

0.19

246

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

788

7106

1.12

2.33

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

602

1.40

2.31

1.9

1.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.04

2.31

1.1

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2903

27686

1.07

2.28

4.8

4.7

22.33

22.08

0.37

1471

14250

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.94

2.27

1.1

1.0

0.02

0.10

u/ml

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

246

1.63

2.26

1.2

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

171

1.76

2.23

1.8

2.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

142

1.83

2.22

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.11

2.22

1.0

0.02

0.15

u/ml

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

271

1.59

2.22

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

179

1.73

2.21

1.8

1.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.68

2.20

4.9

3.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

114

1.93

2.19

1.2

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.41

2.19

1.3

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

165

1.76

2.18

1.8

2.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

4.29

2.15

2.3

1.4

346.50

391.07

mg/24h

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.69

2.15

8.9

3.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

250

1.60

2.14

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.16

2.14

1.2

1.0

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

370

1.49

2.13

1.7

1.4

58.50

64.49

0.65

321

(3028717) Thiamine [Mass/volume] in Blood

116

1.90

2.10

1.2

63.68

64.25

ug/l

0.05

116

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

331

1.51

2.10

1.2

1.3

12.28

11.04

mm/h

0.26

331

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.90

2.07

1.0

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

2.90

2.07

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

728

1.34

2.05

1.0

336.05

334.96

ng/l

0.01

513

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

729

1.33

2.03

1.0

669.41

724.93

ng/l

0.60

494

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

207

1.64

2.03

1.0

8.13

9.95

u/ml

0.26

135

(3002619) Bacteria identified in Specimen by Culture

246

1.59

2.03

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

619

1.36

2.00

2.0

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.63

2.00

1.2

2.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.63

2.00

1.0

1.1

290.90

260.78

nmol/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

732

1.33

1.98

1.0

42.33

43.06

ng/l

0.08

508

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.94

1.5

0.23

0.17

nmol/l

0.51

(3014133) Dog dander IgE Ab [Units/volume] in Serum

130

1024

1.27

1.94

1.1

3.01

3.59

u/ml

0.22

487

(3011325) HIV 1+2 Ab [Presence] in Serum

2.73

1.93

1.0

0.08

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

290

1.52

1.91

1.7

1.4

29.42

20.14

1.11

269

(43055514) Macroprolactin [Presence] in Serum or Plasma

135

1.78

1.90

1.3

1.6

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

2.24

1.90

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

220

1.59

1.87

10.8

8.2

7.49

5.26

kpa

2.84

220

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

261

1.53

1.83

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

4.17

1.82

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

160

1.69

1.81

1.9

2.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

121

955

1.27

1.80

1.1

2.06

3.57

u/ml

1.18

403

(3001893) Eosinophils/Leukocytes in Pleural fluid

319

1.48

1.80

1.6

1.4

1.97

2.33

0.28

282

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

116

1.81

1.78

1.3

1.1

16.47

20.07

u/l

0.63

(3011048) Pyruvate [Moles/volume] in Blood

2.34

1.77

1.1

1.2

91.09

80.67

umol/l

0.44

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

109

1.84

1.76

1.0

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.33

1.74

1.0

2.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.03

1.74

2.7

1.7

44.34

43.16

umol/l

0.09

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

439

1.39

1.72

1.3

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

172

2072

0.83

1.71

1.4

1.6

930.12

1011.74

mu/l

0.56

137

1719

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.88

1.70

1.2

1.3

125.80

93.08

ug/l

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

234

1.54

1.69

1.9

1.7

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.18

1.67

1.4

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

623

1.32

1.65

1.1

259.17

292.04

mg/l

1.04

557

(3036048) Francisella tularensis Ab [Titer] in Serum

212

1.56

1.64

1.1

1.2

—

421.54

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.57

1.61

1.2

4.18

1.91

mu/l

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.38

1.61

1.0

1.2

1.00

1.12

u/field

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

254

1.50

1.59

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

601

1.32

1.59

2.0

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.00

1.58

2.0

181.98

253.75

ug/l

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

129

1.71

1.56

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

129

1.71

1.56

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

129

1.71

1.56

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

322

1.43

1.54

2.6

3.2

28.17

27.91

umol/l

0.05

242

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

750

0.73

1.53

1.5

66.06

60.95

ug/l

0.28

750

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.90

1.49

3.0

5.7

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.95

1.48

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

710

0.73

1.47

1.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.22

1.46

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

132

1.67

1.45

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

245

1.47

1.41

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

431

1.35

1.40

1.1

—

0.12

—

(1002224) Polysomnography panel

419

3775

1.11

1.38

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

112

1.70

1.35

1.6

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

273

1.43

1.34

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

273

1.43

1.34

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

273

1.43

1.34

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

273

1.43

1.34

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

315

1.40

1.34

1.1

—

(40768795) Lymph node Pathology biopsy report

125

1032

1.21

1.33

1.3

1.2

—

(3019174) dRVVT (LA screen)

1.97

1.32

1.3

1.2

—

(3005570) Glucose [Moles/volume] in Urine

114

937

1.22

1.28

2.3

2.0

—

1.00

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

114

1.67

1.27

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.94

1.27

1.3

1.2

—

(40765096) Chromosome analysis panel by Banding

310

1.39

1.27

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

863

8071

1.08

1.26

2.5

2.3

12.42

12.94

nmol/l

1.13

760

7265

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1125

0.81

1.25

1.4

1.5

1.22

1.15

ratio

0.17

659

(44806420) Estimation of glomerular filtration rate

923

0.79

1.23

3.1

2.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.97

1.22

1.3

1.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.63

1.21

1.6

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.63

1.21

14.0

8.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

460

1.31

1.21

1.2

1.1

1.25

1.12

u/l

0.60

194

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

505

1.29

1.19

1.2

1.1

16.13

19.85

u/ml

0.27

195

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1127

0.81

1.18

1.3

1.5

1.06

0.95

ratio

0.69

661

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1127

0.81

1.18

1.3

1.5

1.17

1.21

ratio

0.14

664

(3017509) Phencyclidine [Presence] in Urine

1.93

1.16

2.2

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

136

1604

0.85

1.16

4.0

3.9

37.86

40.35

u/ml

0.08

131

1557

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1114

0.82

1.16

1.3

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

333

1.35

1.16

1.4

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

882

0.79

1.16

1.9

1.8

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

1.16

0.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.50

1.15

1.0

2.46

2.13

u/ml

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

150

1.53

1.14

1.7

1.4

3.64

11.29

3.01

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

610

0.75

1.13

1.2

1.3

190.44

181.09

pmol/l

0.18

610

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

119

1.60

1.11

1.3

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

345

1.33

1.10

1.6

1.2

3.13

4.16

umol/l

1.19

312

(3014599) Egg white IgE Ab [Units/volume] in Serum

390

1.31

1.08

1.1

1.0

3.84

0.75

u/ml

0.61

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.65

1.06

2.1

1.7

—

(3000285) Sodium [Moles/volume] in Blood

213

1.41

1.01

1.3

1.2

138.75

138.43

mmol/l

0.12

173

(3047352) Trisomy 18 risk [Likelihood] in Fetus

952

0.82

1.00

1.4

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.00

1.00

22.1

14.9

102.29

106.14

g/l

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

431

1.28

0.99

1.3

79.40

65.94

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

101

1200

0.84

0.98

1.4

1.5

60.21

59.99

ug/l

0.01

986

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.84

0.98

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

224

1.38

0.96

1.3

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

550

1.24

0.95

5.4

7.2

69.51

152.62

ug/l

0.53

351

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.73

0.92

1.1

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.82

0.92

1.4

306.10

319.82

umol/24h

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

644

0.79

0.91

1.4

1.5

4.52

4.51

ug/l

0.00

535

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

984

0.83

0.91

1.5

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.63

0.90

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

270

1.33

0.90

1.1

—

(3005033) Fetal Nuchal fold Thickness US

937

0.83

0.88

1.3

1.5

1.29

1.27

0.09

652

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.61

0.87

3.5

2.2

0.58

0.62

ug/l

0.21

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

169

1.42

0.87

1.0

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.00

0.87

1.2

1.1

7.78

8.20

mmol/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

572

0.79

0.86

1.2

1.3

—

(3001729) Color of Synovial fluid

1.63

0.84

1.5

—

(3014891) Appearance of Pleural fluid

137

1.46

0.83

1.6

1.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

197

1.37

0.81

2.8

2.5

6.61

7.86

mmol/l

1.25

121

(3032868) Hemoglobin electrophoresis panel in Blood

1.61

0.81

1.7

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

979

0.85

0.79

1.4

1.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.82

0.79

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

104

896

1.16

0.78

1.1

1.0

0.29

0.32

u/ml

0.04

274

(4027681) Cerebrospinal fluid IgG ratio and IgG index

474

1.22

0.78

1.2

0.53

0.60

ratio

0.88

271

(3000034) Microalbumin [Mass/volume] in Urine

100

860

1.16

0.77

3.2

3.1

84.68

46.06

mg/l

0.75

630

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

245

2686

0.91

0.76

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

280

1.29

0.73

1.8

2.65

1.72

u/ml

—

(3003577) Lead [Moles/volume] in Blood

1.61

0.72

1.0

1.3

—

0.12

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

117

1.45

0.71

1.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.75

0.71

1.4

1.5

199.57

554.62

nmol/l

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

194

1.34

0.71

1.5

1.4

1.18

1.17

mmol/l

0.37

194

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1008

0.86

0.69

3.3

4.2

25.91

63.09

u/ml

4.13

996

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.56

0.68

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

1.67

0.68

1.1

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.59

0.68

1.2

1.1

8.73

13.20

u/l

0.50

(3015076) Soybean IgE Ab [Units/volume] in Serum

365

1.23

0.67

1.1

1.0

0.18

1.31

u/ml

0.57

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

465

1.21

0.67

9.2

5.8

56.00

9187.49

u/ml

0.55

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

111

1.44

0.65

1.3

1.1

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

121

1.41

0.62

1.2

1.3

55.83

57.61

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

130

1.39

0.61

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

123

1373

0.89

0.59

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.53

0.59

1.1

1.8

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.53

0.59

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

175

1.31

0.58

2.6

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

231

2135

1.08

0.58

1.4

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

273

1.25

0.57

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.48

0.57

1.0

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

116

1.38

0.54

1.6

1.2

—

81.41

—

(3025577) Chromium [Mass/volume] in Blood

636

1.15

0.53

2.3

2.2

2.09

2.45

ug/l

0.52

527

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

121

1091

1.11

0.52

1.3

7.48

7.54

mmol/l

0.07

110

945

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

109

1.38

0.50

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

1.46

0.50

1.0

1.5

15.90

17.94

mmol/l

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.46

0.50

1.0

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.56

0.48

10.1

7.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.43

0.45

2.3

2.5

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

237

1.22

0.45

5.6

5.9

68.86

70.23

0.11

189

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

165

1.27

0.44

2.4

3.7

131.00

147.28

ng/l

0.12

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.45

0.44

1.3

1.1

86.40

93.22

titre

—

(40758292) HTLV I+II Ab panel - Serum

174

0.75

0.43

1.6

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

104

1.35

0.43

1.2

6.08

6.76

mmol/l

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

272

0.81

0.41

1.5

—

(3026470) Cobalt [Mass/volume] in Blood

654

1.12

0.39

2.3

2.1

2.54

3.89

ug/l

2.03

603

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.63

0.35

1.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

395

1.14

0.34

1.2

1.1

44.00

452.63

ng/l

1.93

113

(3020874) Milk IgE Ab [Units/volume] in Serum

406

1.13

0.33

1.1

1.0

0.78

1.91

u/ml

0.54

121

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.67

0.32

1.0

1.1

16.00

7.60

u/ml

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

760

1.09

0.32

1.3

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

147

1.22

0.30

1.1

22.69

36.30

iu/ml

0.90

147

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

111

1.26

0.30

2.7

6.4

9.07

7.95

0.40

111

(40761995) Spermatozoa Progressive [#/volume] in Semen

111

1.26

0.30

1.4

3.2

36.50

43.95

0.67

111

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

139

1.22

0.29

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.29

0.28

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

393

1.12

0.28

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.25

0.27

1.0

—

(3034092) Cytoplasmic Ig cells/cells in Blood

118

0.76

0.27

8.2

9.2

0.43

0.20

—

118

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.23

0.27

5.6

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

196

1.17

0.27

1.2

2.0

1.65

2.37

ug/l

—

114

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

199

1.16

0.23

1.1

1.2

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.23

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2078

20582

1.01

0.18

3.3

0.74

0.80

ug/l

1.70

1527

13862

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.13

0.18

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.21

0.18

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.72

0.16

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

110

1051

1.05

0.16

1.5

1.4

0.30

0.33

nmol/l

0.17

766

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

178

1.12

0.15

7.7

6.9

10.59

10.34

0.17

178

(40765089) Chromosome analysis panel - Blood by G-banded

150

1.13

0.14

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

150

1.13

0.14

1.5

0.57

0.50

e9/l

0.52

150

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

100

0.80

0.13

1.5

1.9

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

108

0.83

0.13

2.1

1.9

—

(3020650) Glucose [Presence] in Urine

316

1.08

0.12

2.1

1.6

0.03

0.04

estimate

0.09

316

(40768793) Breast Pathology biopsy report

218

2231

0.98

0.11

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

434

0.94

0.10

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

106

1.13

0.09

1.2

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

194

1.08

0.09

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

206

2097

0.98

0.08

5.1

3.4

24.78

28.94

mg/l

1.11

149

1461

(3046861) Legionella sp Ag [Presence] in Urine

1.08

0.08

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.03

0.07

1.0

1.2

69.43

66.79

ug/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

287

2837

1.01

0.06

1.6

1.7

4.43

4.36

mg/l

0.05

233

2082

(3001019) Free T4 and TSH panel - Serum or Plasma

349

3523

0.99

0.05

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

133

1.05

0.01

2.4

2.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

133

1.05

0.01

1.3

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

196

1.02

0.00

7.4

6.0

10.05

8.49

mmol/l

1.42

196

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

234

0.98

0.00

1.5

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

292

0.99

0.00

2.8

1.7

8.19

339.62

pmol/l

—

(40762814) Titanium [Mass/volume] in Blood

161

0.99

0.00

2.3

2.4

3.40

4.18

ug/l

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.85

0.00

1.0

1.1

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

16.50

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

0.03

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.3

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.3

—

6.16

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.3

—

6.81

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

34.20

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.2

—

74.00

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

7.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

8861.20

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_OTHGASTR and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_OTHGASTR	1.377 [1.28, 1.48]	< 0.001
Birth year	0.997 [0.99, 1.01]	0.501

During the follow-up period (1.1.1998 — 31.12.2019), 8632 out of 32208 females with K11_OTHGASTR died.

Males

Parameter	HR [95% CI]	p-value
K11_OTHGASTR	1.712 [1.57, 1.87]	< 0.001
Birth year	0.986 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 8926 out of 27343 males with K11_OTHGASTR died.

Mortality risk

Mortality risk for people of age

years, who have K11_OTHGASTR.

N-year risk	Females	Males
1	0.127%	0.321%
5	0.771%	1.997%
10	1.999%	4.607%
15	3.805%	8.509%
20	6.889%	14.092%

Relationships between endpoints

↥

Index endpoint: K11_OTHGASTR – Other gastritis (incl. Duodenitis)

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other gastritis (incl. Duodenitis)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints